1
|
Maltes S, Rocha BML, Cunha GJL, Paiva MS, Vasques AC, Freitas P, Guerreiro S, Marta L, Abecasis J, Regina R, Andrade MJ, Aguiar CT, Martins A, Mendes M. Prevalence of RV dysfunction in patients under cardiotoxic chemoterapy: a preliminary analysis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Chemotherapy-induced cardiotoxicity is a serious complication often leading to heart failure. While the left ventricle (LV) has been thoroughly implicated in this process, data is scarce on right ventricular (RV) function following cardiotoxic chemotherapies. Our goal was to determine the prevalence and clinical significance of RV dysfunction in a cohort of patients who had received these drugs.
Methodology
Single-center retrospective study of cancer patients performing 2D transthoracic echocardiogram between January 2020 and December 2021. Those previously exposed to anthracyclines and/or anti-HER2 agents (≥6 months prior to echocardiogram) were included. Patients with known coronary artery disease or cardiomyopathy were excluded. LV function was assessed through LV ejection fraction (LVEF) and global longitudinal strain (GLS). LV cardiotoxicity was defined as per 2020 ESMO guidelines. RV function was considered abnormal if the following criteria were met: tricuspid annular plane systolic excursion (TAPSE) <17 mm, peak systolic velocity of the tricuspid annulus by pulsed wave TDI (S'VD) <12 cm/s, fraction area change (FAC) <35% and mean free wall longitudinal strain (FWLS) >−20%.
Results
Forty patients were included (58±13 years; 95% female; 93% with breast cancer; 30%, 20% and 50% previously treated with anthracyclines, anti-HER2 or both, respectively). Mean LVEF and GLS were 56±7% and −17±3%. Overall, 13 patients had current LV cardiotoxicity. RV dysfunction was documented in 15 (38%) patients (7 [18%] with isolated RV dysfunction), most often detected through FWLS (14 [35%], 7 [18%], 6 [15%] and 5 [13%] patients with abnormal FWLS, TAPSE, FAC and S'VD, respectively) – Figure 1. Seven patients (18%) and one patient (3%) had ≥2 and ≥3 abnormal RV parameters. Those with RV dysfunction were more often symptomatic (NYHA class ≥2: 53% vs. 16%; p=0.013), had higher NT-proBNP levels (516 [204–2400] vs. 66 [46–191] pg/mL; p=0.003) and most often had LV cardiotoxicity (62% vs. 26%, p=0.029); pulmonary artery systolic pressures were similar between both groups.
Conclusion
In our cohort of patients treated with cardiotoxic anti-neoplastic drugs, RV dysfunction was observed in two out of every five patients, most often detected by RV 2D strain and associated with worse symptoms and higher NT-proBNP levels. This data suggests that RV cardiotoxicity may be common and clinically impactful in those under cardiotoxic chemotherapies.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - M S Paiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - A C Vasques
- Hospital de Sao Francisco Xavier , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Marta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - R Regina
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - A Martins
- Hospital de Sao Francisco Xavier , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
2
|
Gomes D, Reis Santos R, Freitas P, Presume J, Mendes G, Coutinho Santos A, Guerreiro S, Abecasis J, Ribeiras R, Andrade MJ, Campante Teles R, Saraiva C, Mendes M, M Ferreira A. Indexing calcium score of the aortic valve to the annulus area improves the grading of aortic stenosis severity in patients within the grey zone of aortic valve calcification. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Calcium score of the aortic valve (CaScAoV) is recommended as a supporting tool to assist in the grading of aortic stenosis (AS) severity when echocardiographic assessment is inconclusive. However, a significant proportion of patients have CaScAoV values within a “grey zone” between the “unlikely” and “likely” thresholds. The purpose of this study was to assess the potential usefulness of indexing CaScAoV to the area of the aortic annulus, in order to improve the discriminative power of CaScAoV in this subset of patients.
Methods
Consecutive patients evaluated at a single center TAVI program were retrospectively identified and included in the analysis if cardiac CT and echocardiography were performed within a 6-month timeframe. Those with LVEF <50%, indexed stroke volume <35 ml/m2, rheumatic heart disease, or bicuspid aortic valves were excluded. Severe AS was defined as mean transvalvular gradient ≥40 mmHg. The likelihood of severe AS assessed by CT was categorized according to the guideline-recommended sex-specific CaScAoV thresholds. Patients were considered to be in the “grey zone” if their CaScAoV values were between 800–1200 for women, and between 1600–2000 for men.
Results
A total of 655 patients were included (282 men (43.1%), median age 83 years [IQR 79–86]). AS was considered severe by echocardiographic criteria in 587 patients (89.6%), and moderate in the remainder. Median transvalvular gradient was 49 mmHg (IQR 43–59), and median CaScAoV values were 3329 (IQR 2356–4500) for men, and 1995 (IQR 1462–2781) for women.
Overall, 77 patients (11.7%) had CaScAoV values in the “grey zone”, of which 24 (31.2%) had moderate AS (Figure 1). Patients within this region of uncertainty were no different form the others in terms of age, sex, annulus size and body surface area.
In this subset of patients, indexing CaScAoV to aortic annulus area showed good discriminative power to identify severe AS (AUC 0.69, 95% CI 0.56–0.81, p=0.008). Using previously established thresholds (>300 AU/cm2 for women and >500 AU/cm2 for men), 48 patients (62.3%) were correctly reclassified (net reclassification index of 0.45, p=0.03). These findings were similar for both sexes.
Conclusion
In patients undergoing cardiac CT for known or suspected severe AS with CaScAoV values within the “grey zone”, indexing CaScAoV to the area of the aortic annulus improves the classification of AS severity and may decrease diagnostic uncertainty.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- D Gomes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | - J Presume
- Hospital Santa Cruz , Lisbon , Portugal
| | - G Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | | | | | - C Saraiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | | |
Collapse
|
3
|
Maltes S, Lima R, Santos RR, Freitas P, Lopes PMD, Marta L, Guerreiro S, Abecasis J, Ferreira A, Ribeiras R, Andrade MJ. A preliminary analysis regarding functional mitral regurgitation grading with echocardiography and CMR: in search of similarities and resolving discordances. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1542] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Functional mitral regurgitation (fMR) severity grading by 2D transthoracic echocardiography (TTE) can be a complex task, especially in patients where PISA assumptions are not met (eg. non-circular orifice or multiple jets). Cardiac magnetic resonance (CMR) can provide further insight on the hemodynamic burden of fMR by accurately determining mitral regurgitant fraction (RegFrac). Our goal was to investigate the concordance and disagreement between the two modalities in assessing fMR.
Methodology
Single-center prospective study of fMR patients performing same-day TTE and CMR from Feb to Dec 2021. MR severity was classified according to 2020 ACC consensus: grade I (mild; EROA <0.20 cm2), grade II (moderate; EROA 0.20–0.29 cm2), grade III (moderate-to-severe; EROA 0.30–0.39 cm2) and grade IV (severe; EROA ≥0.40 cm2). MR assessment by CMR was determined through regurgitant volume (RVol) and RegFrac quantification. A RegFrac ≥35% (recently shown as the best cut-off for prognostication) was considered hemodynamically significant.
Results
A total of 36 patients were included (age 65±14y; 74% male; left ventricle [LV] ejection fraction by TTE and CMR 35±13% and 34±11%, respectively). Mean RVol and EROA by TTE were 28±11mL and 0.18±0.8 cm2. Mean RVol and Regfrac by CMR were 20±13 mL and 25±12%, respectively. A moderate correlation between RVol by TTE and CMR was found (Pearson's R 0.58, p=0.001). According to TTE, there were 20 patients (56%) with grade I fMR, 12 patients (33%) with grade II fMR and 4 patients (11%) with grade III fMR. All patients considered to have mild (grade I) fMR by TTE had a RegFrac <35% at CMR. However, amongst those with moderate and moderate-to-severe (grades II and III) fMR, there were 8 patients (50%) with hemodynamic significant fMR (RegFrac ≥35%) at CMR – see Figure 1. Those with RegFrac ≥35% by CMR had higher indexed LV diastolic (165±24 vs 139±48 mL/m2) and systolic (116±31 vs 95±48 mL/m2) volumes and higher pulmonary artery systolic pressures (48±14 vs 41±16 mmHg) when compared with patients whose RegFrac was <35%, even though statistically significance was not reached.
Conclusion
Using the criterion of RegFrac ≥35%, CMR re-classifies (half for each side) the patients with moderate and moderate-to-severe regurgitations by TTE. Recognizing, overcoming and resolving the disagreements between the techniques is the way forward to reach excellence.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | - R Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Marta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | | |
Collapse
|
4
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Guerreiro S, Padrao C, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Neves JP, Ramos S, Mendes M. Relative apical sparing in severe aortic stenosis: does it mean concomitant amyloid cardiomyopathy? Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.137] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Relative apical sparing (RAS) of left ventricular (LV) longitudinal strain (LS) is a red flag marker for the suspicion of amyloid cardiomyopathy. However, it has also been described in patients with severe aortic stenosis (AS).
Aim
To assess the prevalence of RAS in patients with severe symptomatic AS referred for surgical aortic valve replacement (AVR), to evaluate its clinical significance and assess its presence after surgery.
Methods
We prospectively studied 135 consecutive patients (age: 73 y [IQR 68–77 y], 49% men) with severe symptomatic AS – mean transaortic pressure gradient (AVmean): 60.9±17.7 mmHg; mean aortic valve area: 0.7±0.2 cm2, referred for surgical AVR with no previous history of ischemic cardiomyopathy or other. Beyond 12 lead-ECG and transthoracic echocardiography (TTE), all patients underwent cardiac magnetic resonance (CMR) before surgery. RAS was defined by the ratio >1 of average LS at apical segments/sum of the average basal and mid LS at speckle tracking analysis. AVR with septal myocardial biopsy, for investigational purposes, was performed in 80 patients. AS severity indexes, LV remodeling and tissue characterization parameters were compared in both groups of patients, with and without RAS. LS deformation pattern was reassessed at 3–6 months after AVR.
Results
RAS was present in 24 patients (18%). In the whole cohort there were neither pseudoinfarct pattern or low voltage ECG criteria, nor infiltration suspicion from CMR (native T1 value 1053 ms [IQR 1025–1071 ms] for institutional reference values: 972–1070 ms; ECV 24% [IQR 21–27%]). None of the patients had amyloid deposition at histopathology. Overall, mean CMR LV ejection fraction (LVEF) was 59.6±10.5% and 98 patients (74%) had non-ischemic delayed enhancement, with a median fibrosis fraction of 4.1% [IQR 1.6–7.8%]. RAS cohort had a significantly higher AVmean gradient, relative wall thickness, maximum septal thickness, peak systolic dispersion, with lower global LS at TTE, as well as higher LV mass and lower LVEF at CMR. RAS group has also higher NT-proBNP ambulatory values (Table 1). Follow-up evaluation after AVR revealed RAS disappearance in 19 patients (79.2%).
Conclusions
RAS occurs in almost one-fifth of the patients in this cohort despite the absence of signs of myocardial infiltration. This deformation pattern elapses with worse indexes of LV remodeling consistent with a more advanced stage of the disease, being reversible after AVR, which stands for the absence of concomitant myocardial infiltration.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - C Padrao
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| | - S Ramos
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
5
|
Lopes P, Albuquerque F, Freitas P, Goncalves PA, Presume J, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Influence of age on the diagnostic value of coronary artery calcium score for ruling out coronary stenosis in symptomatic patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The 2021 Guideline for the Evaluation of Chest Pain supports the use of coronary artery calcium (CAC) score as a reasonable first-line test to identify patients with a low likelihood of obstructive coronary artery disease (CAD) who may not require additional testing (class IIa, LOE B). However, a recent study from a large cohort of Northern European patients raised concerns about the added diagnostic value of CAC=0 in younger patients. The aim of this study was to assess the influence of age on the value of CAC=0 in symptomatic patients undergoing coronary computed tomography angiography (CCTA).
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality, according to the guideline-recommended method. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The diagnostic likelihood ratios and negative predictive values (NPV) were used to assess the diagnostic value of a CAC score of 0 to rule out obstructive CAD.
Results
A total of 2043 patients (mean age 60±11 years, 60% women) of whom 990 (48.5%) had a CAC score of 0 were included in the analysis. Symptom characteristics were: 38% non-anginal chest pain, 30% atypical angina, 19% dyspnea, and 13% typical chest pain. Overall, the prevalence of obstructive CAD was 12.8% (n=262). Pretest probability of obstructive CAD increased progressively with age, from 6.0% in patients young than 50 years to 20.7% in those 70 years or older. Contrariwise, the prevalence of patients with a CAC score = 0 decreased from 77% in patients younger than 50 years, to 26% in those who where 70 years or older.
The added diagnostic value of a CAC score = 0 was lower in younger patients, with negative likelihood ratios ranging from 0.36 (64% decrease in the likelihood of CAD) in patients younger than 50 years, to 0.09 and 0.10 (∼90% decrease in the likelihood of CAD) in those aged 60–69 years and 70 years or older, respectively – Figure 1.
Despite this, the prevalence of obstructive CAD among patients with a CAC score = 0 was low across all age groups: 2.4% (i.e., NPV = 97.6%) in those younger than 50 years, 3.0% (NPV = 97.0%) among those aged 50–59 years, 1.5% (NPV = 98.5%) in patients between 60 and 69 years, and 2.0% (NPV = 98.0%) among those 70 years or older.
Conclusions
In a cohort of symptomatic patients undergoing CCTA for suspected CAD, the added diagnostic value of a CAC score of zero decreases significantly at younger ages. However, this “diminishing return” of CAC in younger patients if offset by their lower pretest probabilities, yielding high negative predictive values independently of age.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - J Presume
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A C Santos
- Hospital Santa Cruz , Carnaxide , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
6
|
Presume J, Paiva M, Gomes D, Albuquerque F, Guerreiro S, Marta L, Freitas P, Trabulo M, Abecasis J, Andrade MJ, Ribeiras R. Severe rheumatic mitral stenosis – analysis of clinical and echocardiographic very long-term outcomes after percutaneous mitral balloon valvuloplasty. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Mitral balloon valvuloplasty (MBV) is the guideline recommended treatment for symptomatic severe mitral stenosis (MS) with suitable anatomy, but is often deemed transitory. However, data on very-long term echocardiographic follow-up is scarce. The aim of our study was to describe clinical and echocardiographic outcomes in patients previously submitted to MBV for rheumatic MS.
Methods
We conducted a single-centre retrospective study enrolling patients previously submitted to MBV for rheumatic MS from 1990 until 2021. Follow-up was considered until last registered echocardiographic re-evaluation. Patients without electronic health records available were excluded. The primary endpoint was a composite of all-cause death or need of surgery.
Results
A total of 193 patients were included (15.5% male, with a mean age of 52±15 years at the time of MBV, 60.6% with permanent atrial fibrillation). During a mean follow-up of 11±8 years, 87 (45.1%) patients implanted a mitral valve prosthesis, 4 (2.1%) were submitted to surgical mitral valvuloplasty and 30 (15.5%) died without being reinterventioned. Moreover, a total of 23 (11.9%) embolic events were registered – 21 strokes, 1 pulmonary embolism and 1 acute lower limb embolism.
Overall, 133 patients (68.9%) survived more than 5 years, 95 (49.2%) more than 10 years and 56 (26.9%) more than 15 years since MBV without meeting the primary endpoint. The maximum follow-up without intervention was 32 years. Concerning patients submitted to surgery, the mean time from MBV until operation was 9.4±7.3 years (minimum 8 days; maximum 29.3 years).
In regard to echocardiographic long-term outcomes on alive non-operated patients (mean follow-up of 12±9 years), 52.8% remain with mild MS, 91.6% with mild or no mitral regurgitation and 77.6% with mild or no tricuspid regurgitation. Furthermore, only 20.4% have right ventricle dysfunction (defined as a TAPSE <17 mm), 18.3% have pulmonary hypertension (pulmonary artery systolic pressure >45 mmHg), and 6.8% have residual interatrial communication.
Conclusion
MBV is a minimally invasive procedure that has an important benefit in a very significant proportion of patients with rheumatic mitral stenosis, with potential benefit that may last more than three decades without need for another invasive intervention.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- J Presume
- Hospital de Santa Cruz , Lisbon , Portugal
| | - M Paiva
- Hospital de Santa Cruz , Lisbon , Portugal
| | - D Gomes
- Hospital de Santa Cruz , Lisbon , Portugal
| | | | | | - L Marta
- Hospital de Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital de Santa Cruz , Lisbon , Portugal
| | - M Trabulo
- Hospital de Santa Cruz , Lisbon , Portugal
| | - J Abecasis
- Hospital de Santa Cruz , Lisbon , Portugal
| | | | - R Ribeiras
- Hospital de Santa Cruz , Lisbon , Portugal
| |
Collapse
|
7
|
Maltes S, Abecasis J, Pinto DG, Santos RR, Oliveira L, Mendes GS, Guerreiro S, Lima T, Freitas P, Ferreira A, Ramos S, Felix A, Cardim N, Gil VM, Mendes M. Histology-verified myocardial fibrosis and quantification in severe AS patients: correlation with non-invasive LV myocardial tissue assessment. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Myocardial fibrosis (MF) is a common finding and a potential adverse prognostic marker in several cardiac diseases, including in severe aortic stenosis (AS). While histological analysis obtained through endomyocardial biopsy remains the gold-standard for MF assessment, non-invasive cardiac imaging may offer surrogate biomarkers for fibrosis. We tried to assess the correlation between MF quantification at histopathology and cardiac magnetic resonance (CMR)-derived tissue characterization data in patients with severe AS.
Methodology
Single-center prospective cohort enrolling 71 patients with severe symptomatic high-gradient AS undergoing surgical aortic valve replacement (SAVR) (mean age 71±9 years; 49% male, mean valvular transaortic gradient 60±20 mmHg; mean left ventricle [LV] ejection fraction 58±9%). Those with past history of myocardial infarction or cardiomyopathy were excluded. All patients underwent pre-operative CMR study with LV tissue characterization and quantification. Normal T1 mapping value was defined as >1021ms as per center protocol. Myocardial tissue was obtained during SAVR either through myocardial biopsy at basal LV septum or harvested from surgical myectomy specimens. Masson's trichrome stain was used for collagen/fibrosis assessment. Automatic quantification was obtained at QuPathTM digital pathology software after applying a dedicated artificial intelligence algorithm on ultra-high-resolution digital slide scanning images.
Results
Histology-confirmed MF was observed in all patients (median percentage of fibrotic myocardial tissue 15% [IQR 9–22%]). Median global T1 mapping and extracellular volume (ECV) percentage was 1048ms (IQR 1027–1078) and 24% (IQR 20–30%), respectively. Late gadolinium enhancement (LGE) with a non-ischemic pattern was present in 42 patients (59%) with a median LGE mass of 5.8g [IQR 1.0–10.2]; median percentage of 3.7% [IQR 0.6–10.4]. While neither T1 mapping (global or basal LV septum), ECV nor LGE had any significant correlation with histology-confirmed MF (Figure 1) the vast majority had significantly elevated global and basal LV septum T1 mapping – 81% and 92%, respectively.
Conclusion
In this single-center prospective study, microscopic MF was present in all patients with severe symptomatic high-gradient AS, was accompanied by elevated T1 mapping values but no correlation was found between myocardial fibrosis at histopathology analysis and CMR-derived LV tissue characterization parameters. This may not only stem from sampling (single point biopsy vs. whole myocardial tissue assessment) but also from distinct evaluation of different types of fibrosis by different methods.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - D G Pinto
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | - T Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - S Ramos
- Hospital Santa Cruz , Lisbon , Portugal
| | - A Felix
- Portuguese Institute of Oncology Lisbon , Lisbon , Portugal
| | - N Cardim
- Hospital da Luz, SA , Lisbon , Portugal
| | - V M Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
8
|
Lopes P, Cunha G, Freitas P, Rocha B, Abecasis J, Carmo J, Guerreiro S, Galvao Santos P, Moscoso Costa F, Carmo P, Cavaco D, Morgado F, Mendes M, Adragao P, Ferreira A. The peri-infarct gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than dense core fibrosis in patients with previous myocardial infarction. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Current sudden cardiac death (SCD) risk stratification relies heavily on left ventricular ejection fraction (LVEF), but markers to refine risk assessment are needed. Dense core fibrosis (DCF) and peri-infarct “gray zone” of myocardial fibrosis (GZF) on late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether DCF and GZF could predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction.
Methods
We performed a single centre retrospective study enrolling consecutive patients with previous myocardial infarction undergoing CMR before implantable cardioverter-defibrillator (ICD) implantation. Areas of LGE were subdivided into “core” DCF and “peri-infarct” GZF zones based on signal intensity (>5 SD, and 2–5 SD above the mean of reference myocardium, respectively).
The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device.
Results
A total of 88 patients (median age 61 years [IQR 54–73], 84% male, median LVEF 30% [IQR 23–36%], 14% secondary prevention) were included. During a median follow-up of 23 months [IQR 9–38], 13 patients reached the primary endpoint (10 appropriate ICD shock, 2 sustained VT or VF, and 1 sudden arrhythmic death). Patients who attained the primary endpoint had similar DCF (30.4±14.7 g vs. 28.0±15.3 g; P=0.601) but a greater amount of GZF (18.1±9.6 g vs. 11.9±6.7 g; P=0.005). On univariate analysis, GZF was associated with the composite endpoint (HR: 1.09 per gram; 95% CI: 1.02–1.15; P=0.006), whereas DCF was not (HR: 1.01 per gram; 95% CI: 0.98–1.05; P=0.571). After adjustment for LVEF, GZF remained independently associated with the primary endpoint (adjusted HR: 1.06 per gram; 95% CI: 1.01–1.12; P=0.035). Decision tree analysis identified 11.9g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 11 out of the 35 patients (31.4%) with GZF ≥11.9 g, but in only 2 of the 53 patients (3.8%) with GZF <11.9 g – Figure 1.
Conclusions
The extent of peri-infarct GZF seems to be a better predictor of ventricular arrhythmias than DCF. This parameter may be useful to identify a subgroup of patients with previous myocardial infarction at increased risk of life-threatening arrhythmic events.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - G Cunha
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | - B Rocha
- Hospital Santa Cruz , Carnaxide , Portugal
| | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - J Carmo
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | | | | | - P Carmo
- Hospital Santa Cruz , Carnaxide , Portugal
| | - D Cavaco
- Hospital Santa Cruz , Carnaxide , Portugal
| | - F Morgado
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Adragao
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
9
|
Paiva M, Gomes D, Freitas P, Presume P, Santos R, Lopes P, Matos D, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Ferreira A. Use of coronary calcium score to refine the cardiovascular risk classification of the new SCORE2 and SCORE2-OP algorithms in patients undergoing coronary CT angiography. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Recently, the European Society of Cardiology issued new algorithms (SCORE-2 and SCORE2-OP) to estimate the 10-year risk of atherosclerotic cardiovascular disease (ASCVD). CACS has been shown to reclassify a significant proportion of patients when applied on top of several scores, but data on its use with these new algorithms are lacking.
The aim of this study was to assess the risk reassignment that can be attained by using CACS as a risk modifier of the SCORE-2 / SCORE2-OP classification, in patients referred for coronary CT angiography (CCTA).
Methods
Individuals without diabetes or known ASCVD were included in a single center registry of patients undergoing CCTA for suspected coronary artery disease (CAD). The 10-year risk of cardiovascular disease was calculated for each patient using SCORE-2 (ages 40–69) or SCORE2-OP (ages 70–89), and categorised as low-to-moderate, high, or very-high risk, according to guideline-recommended age-specific thresholds. CACS was considered to reclassify risk one level downward if = 0 in high or very-high risk patients, and reclassify risk upward if >100 (or >75th percentile) in those with low-to-moderate risk, or >1000 in those with high-risk.
Results
A total of 529 patients (43% men, mean age 63±10 years) were included, of which 13% (n=69) were active smokers. The mean systolic blood pressure and non-HDL-C values were 137±18 mmHg and 140±37 mg/dL, respectively.
A total of 47 patients (9%) had obstructive CAD on CCTA, classifying them as very-high risk. In the remainder 482 patients without obstructive CAD, the median CACS was 8 (IQR 0–80 AU), with 194 patients (40%) having CACS = 0, and 111 (23%) presenting CACS values ≥100.
The proportion of patients classified as low-to-moderate risk, high risk, and very high risk was 36%, 46% and 19% using the SCORE-2 / SCORE2-OP algorithm.
Using CACS would reclassify 150 patients (31%): 107 patients (22%) downward, and 43 patients (9%) upward. The extent of risk reclassification conveyed by CACS was 33% in patients assessed with SCORE-2, and 25% with SCORE-2 OP (p=0.082). Overall, most of the risk reassignment (42%, n=93) would occur in patients originally classified as high-risk – Fig. 1.
At the time of testing, 32% (n=61) of patients with CACS = 0 were being treated with statins, whereas 52% (n=58) of those with CACS ≥100 were not.
Conclusion
Even when the most recent SCORE-2 / SCORE-2 OP algorithms are used, risk refinement with CACS leads to the reclassification of nearly one third of the patients undergoing CCTA, mostly from downgrading risk. This opportunistic use of CACS may be employed to improve the allocation of primary prevention therapies.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- M Paiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Gomes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Freitas
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Presume
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - R Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - P Lopes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - D Matos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - S Guerreiro
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - J Abecasis
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Santos
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - C Saraiva
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - M Mendes
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| | - A Ferreira
- Centro Hospitalar de Lisboa Ocidental , Lisbon , Portugal
| |
Collapse
|
10
|
Lopes P, Albuquerque F, Goncalves PA, Presume J, Freitas P, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Implications of the North American 2021 Chest Pain guidelines in the diagnostic approach to patients with stable chest pain and low pretest probability of obstructive coronary artery disease. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
The North American 2021 Chest Pain Guidelines recommend not testing stable patients with low pretest likelihood of obstructive coronary artery disease (CAD), defined as pretest probability <15% using contemporary models (Class I recommendation). In selected cases among this subset of patients, coronary artery calcium (CAC) score is considered a “reasonable first-line test” (Class IIa). Despite some supporting evidence, the clinical implications of a widespread adoption of these recommendations remain unclear.
The purpose of this study was to assess the results of three different testing strategies for patients with pretest probability <15%: A) defer testing; B) perform CAC score and withhold further testing if = 0, and proceed to coronary CT angiography (CCTA) if >0; C) perform CCTA in all.
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients with suspected CAD who underwent CAC score and CCTA. Patients with known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea were excluded. Pretest probability of obstructive CAD was calculated based on age, sex and symptom typicality. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA.
Results
A total of 2259 patients were screened, of which 1385 (61.3%) had pretest probability <15% and were included in the analysis (mean age 57±11 years, 79% women). Symptom characteristics were: 48% non-anginal chest pain, 26% atypical angina, 21% dyspnea, and 5% typical chest pain. Overall, the prevalence of obstructive CAD was 10.3% (n=142). In the 786 patients (56.6%) with a CAC score of 0, 8.5% (n=67) had some degree of CAD [1.9% (n=15) obstructive, and 6.6% (n=52) nonobstructive]. Among those with CAC >0 (n=599), 21.2% (n=127) had obstructive CAD. The results that would be reached with each of the 3 diagnostic strategies are presented in Figure 1. The number of patients needed to scan with strategy B (CAC as gatekeeper) vs. A (no testing) to identify one patient with obstructive CAD was 11, whereas the number needed to scan with strategy C (CCTA for all) vs. strategy B was 91.
Conclusions
Not testing patients with suspected CAD and pretest likelihood <15% would lead to missing obstructive CAD in 1 out of 10 patients. Using CAC as a gatekeeper in this subgroup would decrease the use of CCTA by more than 50%, at the cost of missing obstructive CAD in 1 out of 100 patients. These findings may be used to inform decisions on testing, which will ultimately depend on how much diagnostic uncertainty and missed diagnoses patients and their physicians are willing to accept.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - J Presume
- Hospital Santa Cruz , Carnaxide , Portugal
| | - P Freitas
- Hospital Santa Cruz , Carnaxide , Portugal
| | | | - J Abecasis
- Hospital Santa Cruz , Carnaxide , Portugal
| | - A C Santos
- Hospital Santa Cruz , Carnaxide , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Carnaxide , Portugal
| | - M Mendes
- Hospital Santa Cruz , Carnaxide , Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz , Lisbon , Portugal
| | - A Ferreira
- Hospital Santa Cruz , Carnaxide , Portugal
| |
Collapse
|
11
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Left ventricular remodeling in aortic stenosis patients referred for surgical aortic valve replacement. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) hypertrophy is a common expected finding in aortic stenosis (AS) patients. Cardiac magnetic resonance (CMR) plays an important role as a non-invasive method for determining LV mass and volume, and to characterize the LV remodeling response in AS.
Aim
To assess the prevalence, to describe the patterns and evolution of LV remodeling (by CMR) in AS patients referred for surgical aortic valve replacement (AVR).
Methods
Single-center prospective cohort of 132 consecutive patients (73 years [68–77 years], 49% men] with severe AS: mean transaortic pressure gradient (AVmean): 61±1.5 mmHg; aortic valve area (AVA): 0.7±0.1 cm2, referred for surgical AVR, with no previous history of ischemic cardiomyopathy. Before surgery, all patients underwent electrocardiogram, complete transthoracic echocardiogram (TTE) and CMR for LV assessment and tissue characterization (mean LV indexed mass [LVMi]: 80.3±26.5 g/m2; mean end-diastolic LV indexed volume [LVEDVi]: 84.4±24.5 mL/m2 and median geometric remodeling ratio [M/V]: 0.95 g/mL [IQR 0. 81–1.08 g/mL]). Patterns of LV remodeling were investigated before and after AVR by CMR measurements of LVMi, LVEDVi and M/V. Besides normal LV ventricular structure, four other patterns were considered: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, and adverse remodeling (Figure 1).
Results
Overall, 43% (n=58) of the patients had concentric hypertrophy, 30% (n=40) concentric remodeling, 22% (n=29) normal ventricular geometry, 4% (n=5) eccentric hypertrophy and in two patients we observed an adverse remodeling pattern. AVR was performed in 80 patients. At the 3rd to 6th month post-AVR assessment, LV remodeling changed to: normal ventricular geometry in 46%, concentric remodeling in 31%, concentric hypertrophy in 19%, eccentric hypertrophy in 3% and adverse remodeling in only one patient (Figure 1).
Conclusions
In this group of patients with severe aortic stenosis, concentric hypertrophy was not the sole pattern of LV remodeling and two out of every five still presented a normal ventricular geometry and mass as assessed by CMR. LV response was dynamic after AVR which stands for complex and multifactorial interaction in these group of patients despite similar valvular pathophysiology and therapeutic intervention.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
12
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Cardiac magnetic resonance patterns of left ventricular hypertrophy in aortic stenosis patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) hypertrophy is a known compensatory mechanism to pressure overload in aortic stenosis (AS) patients. However, by cardiac magnetic resonance (CMR) different patterns of LV adaptation are seen in this group of patients.
Aim
To describe the patterns of LV adaptation (by CMR) and to analyze its structure and function indexes in AS patients referred for surgical aortic valve replacement (AVR).
Methods
We prospectively studied 134 consecutive patients (age: 73y [IQR 68–77y], 49% men) with severe symptomatic AS - mean transaortic pressure gradient (AVmean): 61±1.5 mmHg; mean aortic valve area: AVA): 0.7±0.1 cm2, referred for surgical AVR with no previous history of ischemic cardiomyopathy or other. All patients underwent electrocardiogram, 2D transthoracic echocardiogram (TTE) and cardiac magnetic resonance (CMR) before surgery for LV assessment and tissue characterization. Five patterns of LV structure were considered: normal ventricular structure (normal LV mass/volume ratio [M/V], normal LVMi and normal indexed LV end-diastolic volume (LVEDVi); concentric remodeling: increased M/V, normal LVMi; concentric hypertrophy: increased M/V and LVMi; eccentric hypertrophy: increased LVMi and LVEDVi, normal M/V and ejection fraction; and adverse remodeling: dilated left ventricle, increased LVMi and normal M/V in the context of an impaired ejection fraction. Echocardiogram and CMR structural and functional indexes were compared between these groups.
Results
At baseline study, at CMR: mean LV indexed mass [LVMi]: 80.3±26.5 g/m2; mean end-diastolic LV indexed volume [LVEDVi]: 84.4±24.5 mL/m2 and median geometric remodeling ratio [M/V]: 0.95 g/mL [IQR 0. 81–1.08 g/mL]. Overall, 22% patients had normal LV structure, 30% concentric remodeling ventricular geometry, and two patients had an adverse remodeling pattern. LV hypertrophy was the most prevalent pattern and occurred in 48% of subjects (concentric 43%; eccentric 4%). In our cohort, the severity of AS (AVmean (p<0.001), LV function (LV ejection fraction [p<0.001] and Global longitudinal strain [p<0.001]), LV loading conditions (indexed left atrial volume [p<0.001] and E/e' ratio [p<0.001]) and NT-proBNP (p<0.001) were related to the pattern of LV structure (Table 1).
Conclusions
In our cohort, AS patients presented several distinct patterns of LV remodeling. Disease severity, functional repercussion and loading conditions are distinct between them.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
13
|
R Santos R, Abecasis J, Maltes S, Mendes GS, Oliveira L, Horta E, Guerreiro S, Freitas P, Ferreira A, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M, Neves JP. Left ventricular reverse remodeling in post operative aortic stenosis patients: prevalence and predictor(s). Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
In patients with severe aortic stenosis (AS), left ventricular (LV) remodeling is believed to be a compensatory adaptive process which should reverse after aortic valve intervention. However, this is not always the rule and remodeling persistence may negatively impact post-procedural outcomes and survival.
Aim
To assess the prevalence and predictors of morphological LV reverse remodeling in severe symptomatic AS patients after surgical aortic valve replacement (AVR).
Methods
We prospectively studied 75 patients (72y [68–77y], 45% male) with severe symptomatic AS - mean gradient (AVM): 61±17mmHg; mean indexed aortic valve area (AVAi) 0.41±0.10 cm2/m2 with no previous history of ischemic cardiomyopathy, all with high gradient, 4 with low-flow, 81% with hypertension, 27% with type 2 diabetes mellitus and 35% patients with stage 3 chronic kidney disease: median MDR creat clearance: 70.4mL/min [40–102]. All patients performed pre-operative cardiac magnetic resonance (CMR) at a mean period of 3.4 months (0–17 months) before AVR and at the 3–6th months after AVR, for LV reverse remodeling assessment. It was defined as at least the occurrence of one of the following: >15% reduction in LVEDVi; >15% reduction in LVMi by CMR; >10% reduction in geometric remodeling ratio. Clinical, AV severity data, preoperative functional LV and tissue characterization data were analyzed at multivariate regression to predict the occurrence of LV reverse remodeling.
Results
Overall, at pre-operative CMR: mean LV indexed mass (LVMi): 82±28.9 g/m2; mean end-diastolic LV indexed volume (LVEDVi): 87.4±26.6 mL/m2; mean geometric remodeling (LV mass/end-diastolic volume): 0.92±0.2 g/mL. After AVR, at echocardiographic evaluation, no patient had prosthetic obstruction or prosthetic patient mismatch: median LV-Ao gradient 12mmHg [9.1–14 mmHg]; 5 of them had mild paravalvular regurgitation. LV reverse remodeling occurred in 65 patients (88%) (Figure 1A) and these were younger, had significantly smaller preoperative AVAi and higher valvular gradients (Figure 1B). At multivariate analysis, only preoperative AVAi remained an independent predictor (odds ratio 0.85, 95% CI 0.735–0.984, p=0.029).
Conclusions
In this prospective cohort of patients LV reverse remodeling after surgical AVR was highly frequent, occurring in almost nine out of every ten patients.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - L Oliveira
- Hospital Divino Espirito Santo , Ponta Delgada , Portugal
| | - E Horta
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - N Cardim
- Nova Medical School , Lisbon , Portugal
| | - V Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - J P Neves
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
14
|
Lopes Da Cunha GJ, Lopes P, Freitas P, Rocha B, Gomes D, Paiva M, Amador R, Abecasis J, Guerreiro S, Matos D, Rodrigues G, Carvalho MS, Mendes M, Adragao P, Ferreira A. Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden cardiac death. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.677] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
The usefulness of implantable cardioverter defibrillators (ICD) for primary prevention of arrhythmic sudden cardiac death (SCD) in patients with non-ischemic dilated cardiomyopathy (DCM) has been questioned. Efforts to improve risk stratification have included scores such as the “MADIT-ICD benefit score”, and the use of late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR).
The purpose of this study was to evaluate the potential usefulness of these two tools to assess the risk of life-threatening arrhythmias in patients with non-ischemic DCM undergoing ICD implantation for primary prevention of SCD.
Methods
We conducted a single-center retrospective study of consecutive patients who underwent contrast-enhanced CMR before ICD implantation for primary prevention of SCD. Patients with ischemic cardiomyopathy were used as reference. Patients with non-dilated cardiomyopathies were excluded.
The arrhythmic component of the MADIT-ICD benefit score (VT/VF score) was calculated for each patient, and considered high if ≥7, as recommended.
The primary endpoint was the occurrence of SCD or life-threatening arrhythmias (VF or VT >200 bpm). Follow-up was performed by device interrogation in all patients except those who suffered SCD.
Results
A total of 151 patients (93 ischemic, mean age 62±13 years, 75% male) with mean left ventricular ejection fraction (LVEF) of 27±8% were included. Overall, 72% (n=67) ischemic and 45% (n=26) non-ischemic patients had scores ≥7 and were considered high-risk. LGE was present in all patients with ischemic cardiomyopathy, and in 76% (n=44) of patients with non-ischemic DCM.
During a median follow-up of 21 (8–38) months, 21 patients (13.9%, 11 ischemic and 10 non-ischemic) met the primary endpoint.
Overall, the event-free survival of non-ischemic patients was similar to that of ischemic patients (log rank p=0.269). In patients with non-ischemic DCM, there were 7 arrhythmic events (26.9%) in those with MADIT-ICD VT/VF scores ≥7, and 3 events (9.4%) in those with scores <7 (log rank p=0.104).
In the same population, there were 10 arrhythmic events (23%) in patients with LGE, but no events in patients without LGE (log rank p=0.036).
LVEF was similar in patients with and without arrhythmic events (26±8% vs. 27±7%, p=0.717), and in those with and without LGE (26±7% vs. 28±9%, p=0.342).
Conclusion
The presence of LGE is a strong predictor of life threatening arrhythmias in patients in non-ischemic DCM undergoing ICD implantation for primary prevention, seemingly outperforming the clinical MADIT-ICD benefit score.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - P Lopes
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | - B Rocha
- Hospital Santa Cruz , Lisbon , Portugal
| | - D Gomes
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Paiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - R Amador
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - D Matos
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Adragao
- Hospital Santa Cruz , Lisbon , Portugal
| | | |
Collapse
|
15
|
Maltes S, Abecasis J, Santos RR, Oliveira L, Mendes GS, Guerreiro S, Lima T, Freitas P, Ferreira A, Cardim N, Gil VM, Mendes M. Late gadolinium enhancement patterns in severe symptomatic high-gradient aortic stenosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.233] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Left ventricular (LV) remodeling in patients with severe aortic valve stenosis (AS) is a complex process that goes beyond hypertrophic response and may involve reparative/replacement fibrosis. Currently, cardiac magnetic resonance (CMR) is the gold-standard imaging technique for detecting focal myocardial fibrosis through late gadolinium enhancement (LGE). However, myocardial fibrosis prevalence and distribution is quite variable among series. Our goal was to assess LGE prevalence and distribution pattern in severe symptomatic high-gradient AS.
Methodology
Single-center prospective cohort of 132 patients with severe symptomatic high-gradient AS (mean age 73±11 years; 48% male, mean valvular transaortic gradient 60±20 mmHg; mean aortic valve area 0.7±0.2 cm2/m2; mean LV ejection fraction by 2D echocardiogram 58±9%), all with normal flow (except one) undergoing surgical aortic valve replacement. Those with previous history of acute myocardial infarction, ischemic cardiomyopathy or other cardiomyopathy were excluded. All patients performed 1.5T CMR assessment with LV myocardium tissue characterization prior to surgery. Segmental LGE presence was assessed by two independent operators and classified according to the AHA 16 segment model, using 5-standard deviations from remote myocardium as the signal intensity cut-off for LGE identification and quantification.
Results
Overall, 96 patients (74%) had non-ischemic LGE (median LGE mass 3.2 g [IQR 0.2–8.3] g; median percentage of LGE myocardial mass 2.5% [IQR 0.1–6.1]%); 22 patients [17%] with exclusively junctional LGE); in one patient an incidental ischemic scar (subendocardial distribution) was identified. No cases of subepicardial distribution were found. Intramyocardial LGE was most frequently observed in basal and mid-anterior and inferior interventricular septum – see Figure 1. In these segments, LGE was most often junctional at right-ventricular insertion points (54%), followed by mid-wall LGE (32%) or both sites involvement (14%).
Conclusion
LGE is frequent in symptomatic high-gradient AS patients with preserved left ventricular ejection fraction, most often presenting as junctional enhancement in basal/mid-anterior and inferior interventricular septum. Future studies may address whether distinct LGE patterns may impact patient prognosis.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | | | | | - T Lima
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | | | - N Cardim
- Hospital da Luz, SA , Lisbon , Portugal
| | - V M Gil
- Hospital da Luz, SA , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| |
Collapse
|
16
|
Lopes Da Cunha GJ, Rocha B, Sousa J, Maltes S, Brizido C, Strong C, Guerreiro S, Abecasis J, Andrade MJ, Aguiar C, Saraiva C, Freitas P, Mendes M, Ferreira A. Looking beyond left ventricular ejection fraction – a new multiparametric CMR score to refine the prognostic assessment of HF patients. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.850] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Cardiac magnetic resonance (CMR) is recommended in Heart Failure (HF) to assess myocardial structure and function. Recently, the quantification of pulmonary congestion and skeletal muscle mass using CMR have been shown to predict adverse events in HF, but a tool integrating this information is currently unavailable. The purpose of this study was to develop and test a new multiparametric CMR-derived score.
Methods
We conducted a single-center retrospective study of consecutive HF patients with left ventricular ejection fraction (LVEF) <50% who underwent CMR. Several CMR parameters with known prognostic value were assessed, including: LVEF, Lung Water Density (LWD), Pectoralis Major Muscle (PMM) area, and presence of Late Gadolinium Enhancement. PMM area was outlined at the level of the carina – Figure 1A, B – and LWD was defined as the lung-to-liver signal ratio multiplied by 0.7, as previously described. Both parameters were measured in standard HASTE images - Figure 1C. The primary endpoint was a composite of all-cause death or HF hospitalization. Using the Cox regression Hazard Ratios of designated variables, a risk score was developed.
Results
Overall, 436 patients were included. During a median follow-up of 27 (17–37) months, 43 (9.9%) patients died and 57 (13.2%) had at least one hospitalization for HF. LVEF, LWD and PMM were independent predictors of the primary endpoint and were included in the CMR-HF score – Figure 2. The annual rate of events increased from 4.7 to 7.5 and 20.0% from lowest to highest tertile of the score. Roughly half of the events (54%) occurred in patients in the highest tertile of the CMR-HF score. In multivariate analysis, the new score independently predicted the primary endpoint (HR per 5 points: 1.54; 95% CI: 1.21–1.97; p<0.001) even after adjustment for age, body mass index, NYHA class, NT-proBNP, estimated glomerular filtration rate, presence of implantable cardioverter-defibrillator, and ischemic etiology.
Conclusions
This novel multidimensional CMR-HF score, combining easily obtainable data on left ventricular pump failure, lung congestion and muscular wasting, is a promising tool identifying HF patients with an LVEF <50% at higher risk of death or HF hospitalization.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - B Rocha
- Hospital Santa Cruz , Lisbon , Portugal
| | - J Sousa
- Hospital Santa Cruz , Lisbon , Portugal
| | - S Maltes
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Brizido
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Strong
- Hospital Santa Cruz , Lisbon , Portugal
| | | | | | | | - C Aguiar
- Hospital Santa Cruz , Lisbon , Portugal
| | - C Saraiva
- Hospital Santa Cruz , Lisbon , Portugal
| | - P Freitas
- Hospital Santa Cruz , Lisbon , Portugal
| | - M Mendes
- Hospital Santa Cruz , Lisbon , Portugal
| | | |
Collapse
|
17
|
Lopes P, Albuquerque F, Freitas P, Gonçalves P, Presume J, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Marques H, Ferreira A. 494 Influence Of Age On The Diagnostic Value Of Coronary Artery Calcium Score For Ruling Out Coronary Stenosis In Symptomatic Patients. J Cardiovasc Comput Tomogr 2022. [DOI: 10.1016/j.jcct.2022.06.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
18
|
Paiva M, Gomes D, Freitas P, Presume J, Santos R, Lopes P, Matos D, Guerreiro S, Abecasis J, Santos A, Saraiva C, Mendes M, Ferreira A. 468 Potential Impact Of Replacing Score With Score-2 On Risk Classification And Statin Eligibility - A Coronary Calcium Score Correlation Study. J Cardiovasc Comput Tomogr 2022. [DOI: 10.1016/j.jcct.2022.06.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
19
|
Santos M, Silva M, Guerreiro S, Gomes D, Rocha B, Cunha G, Freitas P, Abecasis J, Carmo P, Cavaco D, Morgado F, Adragao P, Mendes M, Ferreira A. A cardiac magnetic resonance myocardial strain patterns analysis in left bundle branch block. Europace 2022. [DOI: 10.1093/europace/euac053.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Recently, a classification with four types of septal longitudinal strain patterns was described using a speckle tracking based strain analysis in echocardiography suggesting pathophysiological continuum of LBBB-induced LV remodeling. Little data exist on feature tracking cardiac magnetic resonance (FT-CMR) in LBBB patients, and whether such patterns could be reproduced in CMR is not established yet.
Purpose
In this study, we aimed to: 1) Assess and reproduce the new strain patterns classification by CMR and 2) Evaluate its association with LV remodeling and myocardial scar in a LBBB cohort.
Methods
Single center registry which included LBBB patients with septal flash (SF) referred to CMR to assess the structural cause of LV dysfunction. LBBB was defined according to Strauss criteria as strict LBBB, non-strict LBBB or nonspecific LV conduction delay.
A semi-automated FT-CMR was used to quantify myocardial strain and detect the four septal longitudinal and radial strain patterns, according to the recent classification (LBBB-1 through LBBB-4) – Figure. Extent of SF was visually scored as mild, moderate, or prominent.
Results
A total of 115 patients were included (mean age 66±11 years; 57% men; 38% with ischemic heart disease). Median duration of QRS was 150± 26ms and majority of the patients (n=90, 78%) were classified as strict LBBB.
In longitudinal strain analyses LBBB-1 was observed in 23 (20%), LBBB-2 in 37 (32.1%), LBBB-3 in 25 (21.7%), and LBBB-4 in 30 (26%) patients. Patients at higher LBBB stages (longitudinal or radial pattern) had more prominent septal flash, greater LV volumes, lower LV ejection fraction and lower absolute global longitudinal, circumferential and radial strain values compared with patients in less advanced stages (p < 0.05 for all) - table.
There was no difference between patterns in clinical characteristics, ischemic etiology, QRS duration and time delay between septal and lateral LV wall.
Late gadolinium enhancement (LGE) was found in 63 patients (54.8%), with a septal location in 34 (29.6%) patients, lateral in 4 (3.5%) patients, septal and lateral in 11 (9.6%) patients. Furthermore, no difference was found for LGE presence, distribution or location between the four strain patterns.
Conclusions
Among patients with LBBB, our study found a good association between longitudinal and radial strain patterns with the degree of LV remodeling and LV dysfunction by FT-CMR analysis. Additionally, myocardial fibrosis didn’t seem to interfere with the staged LBBB classification.
Collapse
Affiliation(s)
- M Santos
- Hospital Funchal, Funchal, Portugal
| | - M Silva
- Centro Hospitalar Barreiro Montijo, Lisboa, Portugal
| | - S Guerreiro
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - D Gomes
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - B Rocha
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - G Cunha
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Freitas
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - J Abecasis
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Carmo
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - D Cavaco
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - F Morgado
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - P Adragao
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| | - A Ferreira
- Centro Hospitalar de Lisboa Ocidental, Hospital de Santa Cruz, Lisbon, Portugal
| |
Collapse
|
20
|
Sa Mendes G, Abecasis J, Maltez S, Guerreiro S, Freitas P, Horta E, Lima T, Ribeiras R, Andrade M, Cardim N, Gil V. Left ventricular myocardial work in patients with high gradient severe symptomatic aortic stenosis. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Left ventricular myocardial work (LVMW) is a novel method to evaluated left ventricular (LV) function using pressure-strain loops. It might correct global longitudinal strain (GLS) for afterload, being eventually useful to assess whether GLS reduction is due to reduced contractility (reflected as reduced myocardial work) or increased afterload (reflected as increased myocardial work).
Aim
To describe indices of LVMW in a group of patients with severe symptomatic aortic stenosis (AS).
Methods
We prospectively studied 104 consecutive patients (age: 71 years [IQR 66.5–75.5] years, 51% men) with severe symptomatic high gradient AS: mean transaortic pressure gradient: 56.5mmHg [IQR 46.8–67.8]; aortic valve area: 0.73cm2 [IQR 0.61–0.88]; indexed stroke volume: 47.7±1.3 mL/m2 (11 patients with low-flow AS), preserved LV ejection fraction (EV) (LVEF: 56.0% [51.0–61.3]; GLS: −14.5% [IQR −16.1 to −10.6]), with no previous coronary artery disease and no history of cardiomyopathy. Beyond complete transthoracic echocardiography, all patients underwent cardiac magnetic resonance for LV myocardium tissue characterization. As proposed for AS, LV systolic pressure was corrected adding the mean transaortic pressure gradient to non-invasive systolic blood pressure cuff measurement in the echocardiographic algorithm. Four LVMW indices were collected in 83 patients (patients excluded for atrial fibrillation, left bundle branch block or absence of non-invasive blood pressure registration) and correlated to LV function indexes, LV hypertrophy and remodeling, myocardial tissue characterization, BNP and troponin levels (Pearson or Spearman correlation). These same indexes were compared in patients with LV ejection fraction (EF) below and above 50%, normal and reduced flow and presence of replacement fibrosis.
Results
Global constructive work (GCW) (2658.6±76.4mmHg%), global myocardial work (GMW) (2218.7±74.9mmHg%) and global wasted work (GWE) (262.0mmHg% [198.8–339.5]) were high above normal with concomitant lower work efficiency (WE) (88.0% [83.2–91.8]. Weak correlations were found between LVMW indexes and parameters describing aortic valve severity, flow and LV function (table). Except for significant differences of LVMI in patients with reduced LV ejection fraction (GCW 2770.3±687.4 vs 2056.0±380.7mmHg%, p=0,014 and GMW 2362.5±657.9 vs 1621.3±319.9, p=0,021 in patients with LV EF>50% vs. LV EF<50%, respectively) work indexes were neither significantly different in low-flow patients nor in those with myocardial late gadolinium enhancement.
Conclusions
Global constructive and myocardial work are increased in these patients with severe aortic stenosis. This might reflect an increased afterload predominance rather than a LV functional impairment, particularly relevant in this group of patients with exclusive high gradient disease and preserved LVEF.
Funding Acknowledgement
Type of funding sources: None. Correlations between LVMI – LV function
Collapse
Affiliation(s)
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - S Maltez
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - E Horta
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - T Lima
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Andrade
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - N Cardim
- Hospital da Luz, SA, Lisbon, Portugal
| | - V Gil
- Hospital dos Lusiadas, Lisbon, Portugal
| |
Collapse
|
21
|
Gama F, Goncalves PA, Abecasis J, Ferreira AM, Freitas P, Cavaco D, Gabriel HM, Brito J, Raposo L, Adragao P, Almeida MS, Mendes M, Teles RC. Predicting pacemaker dependency after TAVI with pre-procedural MSCT. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background and aim
High degree conduction disturbances is a burdensome complication of transcatheter aortic valve implantation (TAVI). There is limited data whether such disorders are permanent or reversible. Anatomic surrogates, such as membranous septum [MS, a distance marker from aortic annulus to His-bundle surge] and calcium distribution within aortic valve have been associated with pacemaker (PM) implantation. The aim of our study was to assess predictors of long-term pacemaker dependency following TAVI.
Methods
Single center prospectively included patients that underwent pacemaker implantation following TAVI (March 2017 to September 2020). Patients who were lost to follow up, with bicuspid aortic valve, previously implanted PM and non-available or low quality MSCT exam were excluded. On MSCT, MS length was measured on modified coronal view, the aortic-valvular complex (AVC) was characterized by leaflet sector and calcium distribution was assessed on a J-score threshold of 850-Hounsfield units. Pacemaker dependency was assessed by reducing ventricular pacing to 30 bpm and defined by subsequent complete AV dissociation in patients in sinus rhythm or an escape rhythm <50 bpm in atrial fibrillation, in addition of >90% pacing percentage since implantation.
Results
From the 352 patients with inclusion criteria, 67 underwent PM implantation (19%) and 55 included in the analysis (male 33.9%, median age=85) (Figure). Median time for pacemaker implantation was 3 days [interquartile range (IQR) 3–5 days], mostly due to complete auriculo-ventricular block (76.4%, N=42). PM dependency occurred in 14 out of 55 (25.5%) patients at mean follow up of 500±363 days. Patients with PM dependency tended to have deeper implantation depth, (6.2 mm vs 5.5 mm, p=0.096) and a significantly shorter MS (5.8 mm vs 6.8 mm, P-value = 0.031) (Table). Increasing MS length was independently associated with a lower risk of PM dependency [odds ratio (OR) 0.58 per mm; 95% CI: 0.35–0.98, p=0.04] regardless prosthesis choice. MS length under 5 mm had 97.6% specificity (95% CI: 87.1–99.9) and 85.7% positive predictive value for pacemaker dependency (AUC=76.7; 95% CI 63.3–87).
Conclusion
Our findings highlight the importance of MSCT-derived MS length to stratify the risk of long term need for pacemaker. Patients with short MS (<5mm) in addition to conduction abnormality following TAVI had a high likelihood of PM dependency on the long term and should be considered for prompt PM implantation.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- F Gama
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - D Cavaco
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - J Brito
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - L Raposo
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - P Adragao
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - R C Teles
- Hospital de Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
22
|
Albuquerque F, M Lopes P, Freitas P, M Ferreira A, Abecasis J, Trabulo M, Canada M, Ribeiras R, Mendes M, Joao Andrade M. Regurgitant volume to left ventricular end-diastolic volume ratio: the quest to identify Disproportionate MR is not over. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Quantification of secondary mitral valve regurgitation (SMR) remains challenging. Proportionate and Disproportionate SMR provides a conceptual framework that relates the degree of SMR to left ventricular dilatation and dysfunction. In line with this concept, regurgitant volume to LV end-diastolic volume ratio (Rvol/LVEDV) was recently proposed as a possible strategy to identify patients with Disproportionate SMR. The aim of this study was to validate this approach in a Portuguese cohort.
Methods
In a single center cohort of patients with heart failure and reduced left ventricular ejection fraction (HFrEF <50%) under optimal guideline-directed medical therapy (GDMT), we retrospectively identified those with at least moderate SMR. According to the published literature, we divided the study population into 2 risk groups: those with a Rvol/LVEDV ratio ≥20% (greater MR/smaller LVEDV) and those with a ratio <20% (smaller MR/ larger EDV). Cox regression and Kaplan-Meier survival analysis were used to assess the association between Rvol/LVEDV ratio and all-cause mortality.
Results
A total of 154 patients (mean age 69±12 years; 81% male) were included. Mean LVEF was 31±8% and median LVEDV was 193 mL (IQR: 155 to 236 mL). There were 74 patients (48.1%) with a Rvol/LVEDV ratio <20% and 80 patients (51.9%) Rvol/LVEDV ratio ≥20%. Regarding GDMT, 141 (91.6%) received beta-blockers, 139 (90.3%) angiotensin converting–enzyme inhibitors/angiotensin receptor blockers and 77 (50.0%) were under mineralocorticoid therapy. Also, there were patients 49 (31.8%) under cardiac resynchronization therapy and 40 patients (26.0%) had an implantable cardioverter defibrillator. During a median follow-up of 2.1 years (IQR 0.7 to 3.8 years), 92 (59.7%) patients died. Cox regression and survival analysis showed no mortality difference between patients with a Rvol/LVEDV ratio <20% and those with a ratio ≥20% (HR: 1.04; 95% CI 0.69–1.57; P=0.854; Log-rank P=0.967) – see also figure.
Conclusion
In a Portuguese cohort of HFrEF patients under optimized GDMT and with at least moderate SMR, the Rvol/LVEDV ratio was not associated with an increased risk of all-cause mortality. As such, the Rvol/LVEDV ratio does not seem to be a reliable surrogate of Disproportionate SMR, possibly because it does not account for the degree of LV dysfunction.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | - P M Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Canada
- Hospital Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | |
Collapse
|
23
|
Lopes P, Presume J, Goncalves PA, Albuquerque F, Freitas P, Guerreiro S, Abecasis J, Santos AC, Saraiva C, Mendes M, Marques H, Ferreira A. Incorporating coronary calcification into pretest assessment of the likelihood of coronary artery disease: validation and recalibration of a new diagnostic tool. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
A new clinical tool was recently proposed to improve the estimation of pre-test probability of obstructive coronary artery disease (CAD) by incorporating coronary artery calcium score (CACS) with clinical risk factors. This new model (Clinical+CACS) showed improved prediction when compared to the method recommended by the 2019 ESC guidelines on chronic coronary syndromes, but was never tested or adjusted for use in our population. The aim of this study was to assess the performance of this new method in a Portuguese cohort of symptomatic patients referred for coronary computed tomography angiography (CCTA), and to recalibrate it if necessary.
Methods
We conducted a two-center cross-sectional study assessing symptomatic patients who underwent CCTA for suspected CAD. Key exclusion criteria were age <30 years, known CAD, suspected acute coronary syndrome, or symptoms other than chest pain or dyspnea. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. The Clinical+CACS prediction model was assessed for discrimination and calibration. A logistical recalibration of the model was conducted in a random sample of 50% of the patients and subsequently validated in the other half.
Results
A total of 1910 patients (mean age 60±11 years, 60% women) were included in the analysis. Symptom characteristics were: 39% non-anginal chest pain, 30% atypical angina, 19% dyspnea and 12% typical angina. The observed prevalence of obstructive CAD was 12.9% (n=247). Patients with obstructive CAD were more often male, were significantly older, had higher prevalence of typical angina and cardiovascular risk factors, and higher CACS values. The new Clinical+CACS tool showed greater discriminative power than the ESC 2019 prediction model, with a C-statistic of 0.83 (CI 95% 0.81–0.86) versus 0.67 (CI 95% 0.64–0.71), respectively (p-value for comparison <0.001). Before recalibration, the Clinical+CACS model underestimated the likelihood of CAD in our population across all quartiles of pretest probability (mean relative underestimation of 49%), which was subsequently corrected by the recalibration procedure - Figure.
Conclusions
In a Portuguese cohort of symptomatic patients undergoing CCTA for suspected CAD, the new Clinical+CACS model showed better discrimination power than the 2019 ESC method. The underestimation of the Clinical+CACS model was corrected by recalibrating it for our population. This new tool might prove useful for guiding decisions on the need for further testing.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Presume
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P A Goncalves
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz, Lisbon, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A C Santos
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - H Marques
- UNICA – Cardiovascular CT and MR Unit, Hospital da Luz, Lisbon, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
24
|
Lopes P, Freitas P, Ferreira A, Sousa JA, Rocha B, Cunha G, Cavaco D, Abecasis J, Carmo P, Saraiva C, Morgado F, Chotalal D, Feliciano S, Mendes M, Adragao P. The gray zone of myocardial fibrosis is a better predictor of ventricular arrhythmias than total myocardial fibrosis in patients with previous myocardial infarction. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.0216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Current sudden cardiac death (SCD) risk stratification relies heavily on the assessment of left ventricular ejection fraction (LVEF), but markers that could refine risk assessment are needed. Total fibrosis mass (TFM) and “gray zone” of myocardial fibrosis (GZF) on late gadolinium enhancement cardiac magnetic resonance (LGE-CMR) have been proposed as potential arrhythmogenic substrates. The aim of our study was to determine whether TFM and GZF can predict the occurrence of ventricular arrhythmias in patients with previous myocardial infarction.
Methods
We performed a single centre retrospective study enrolling all consecutive patients with previous myocardial infarction undergoing LGE-CMR before implantable cardioverter-defibrillator (ICD) implantation for primary or secondary prevention. TFM and GZF were defined as myocardial tissue with signal-intensities >6 SD and 2–6 SD above the mean of reference myocardium, respectively. The primary endpoint was a composite of sudden arrhythmic death, appropriate ICD shock, ventricular fibrillation (VF), or sustained ventricular tachycardia (VT) as detected by the device.
Results
A total of 55 patients (mean age 62±12 years, 87% male, mean LVEF 30% ± 8%) were included. During a mean follow-up period of 34±15 months, 10 patients reached the primary endpoint (8 appropriate ICD shock, 2 sustained VT or VF). Patients who attained the primary endpoint had similar TFM (28.6g ± 14.5 vs. 23.1g ± 14.5; P=0.283) but larger GZF (25.3g ± 11.0 vs 15.6g ± 7.3; P=0.001). After adjustment for LVEF, GZF remained independently associated with the composite arrhythmic endpoint (adjusted hazard ratio [aHR]: 1.10; 95% CI: 1.03–1.17; P=0.005), whereas TFM did not (aHR: 1.02; 95% CI: 0.98–1.06; P=0.394). Decision tree analysis identified 16.4g of GZF as the best cut-off to predict life-threatening arrhythmic events. The primary endpoint occurred in 9 out of the 22 patients (41%) with GZF >16.4g, but in only 1 of the 33 patients (3%) with GZF ≤16.4g – Figure.
Conclusions
The extent of GZF seems to be a better predictor of ventricular arrhythmias than TFM. This LGE-CMR parameter may be useful to identify a subgroup of patients with previous myocardial infarction at an increased risk of life-threatening arrhythmic events.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J A Sousa
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Chotalal
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
25
|
Maltes S, Abecasis J, Mendes GSM, Padrao C, Reis C, Guerreiro S, Freitas P, Ribeiras R, Andrade MJ, Cardim N, Gil V, Mendes M. Prevalence and determinants of right ventricular dysfunction in patients with severe symptomatic high gradient aortic stenosis. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.1608] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Right ventricular (RV) function in aortic stenosis (AS) has been largely neglected. Recently it was demonstrated that right ventricular impairment may be influenced by left ventricular (LV) function and afterload, well before overt pulmonary hypertension development.
Aim
To describe the prevalence of RV dysfunction in a group of patients with severe symptomatic aortic stenosis (AS) and its relation to LV function parameters and afterload.
Methods
We prospectively studied 93 consecutive patients (age: 73 years [IQR 68–77] years, 55% women) with pure severe symptomatic high gradient aortic stenosis: mean transaortic pressure gradient: 57.0mmHg [IQR 46.9–71.1]; aortic valve area: 0.72cm2 [IQR 0.61–0.88]; indexed stroke volume: 48.8±1.5 mL/m2 (11 patients with low-flow AS), preserved LV ejection fraction (EV) (LVEF: 56.0% [51.0–61.3]; GLS: −14.5% [IQR −16.1 to −10.6]), with no previous coronary artery disease and no history of cardiomyopathy. Beyond complete transthoracic echocardiography, all patients underwent cardiac magnetic resonance (CMR) for LV myocardium tissue characterization (late gadolinium enhancement and extracellular volume). Normal RV function was defined according to TAPSE ≥17mm, tricuspid annular systolic velocity ≥12cm/s, mean free wall longitudinal strain ≤−20%. Patients were divided into four groups: (0) – all three RV parameters below normal (1.1%), (1) – 1 normal parameter (12.9%), (2) – 2 normal parameters (44.1%), (3) – 3 normal parameters (41.9%). Indexes of LV systolic and diastolic function, CMR derived LV geometric remodeling, hypertrophy and tissue characterization, aortic valve disease severity and afterload were compared across the 4 groups of patients. We tried to identify predictors of RV dysfunction (group 0, 1, 2 vs. group 3) at multivariate regression analysis.
Results
Left ventricular performance parameters, diastolic and myocardial work indexes were significantly different across the groups (Figure). Neither AV severity indexes nor LV tissue characterization were distinct. At multivariate analysis only global constructive work was an independent predictor of RV dysfunction.
Conclusion
RV dysfunction is common in this group of patients with severe high gradient aortic stenosis and preserved ejection fraction. RV impairment is significantly related to several LV systolic and diastolic parameters and also to LV afterload, probably accounting for RV-LV interdependence.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
- S Maltes
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | - C Padrao
- Hospital Santa Cruz, Lisbon, Portugal
| | - C Reis
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | - N Cardim
- Hospital da Luz, SA, Lisbon, Portugal
| | - V Gil
- Hospital da Luz, SA, Lisbon, Portugal
| | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| |
Collapse
|
26
|
Sa Mendes G, Lopes P, Campante Teles R, Araujo Goncalves P, Raposo L, Abecasis J, Brito J, Nolasco T, Madeira M, Felix Oliveira A, Goncalves M, Mendes M, Sousa Almeida M. Long-term durability of transcatheter aortic valve replacement: outcomes from a contemporary cohort from a tertiary reference center at 5-years and beyond. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.2172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and aim
Long-term data on the durability of transcatheter heart valves is scarce. This is of particular interest as indications expand to younger and lower surgical risk patients. We sought to assess the incidence of long-term structural valve dysfunction (SVD) and bioprosthetic valve failure (BVF) in a cohort of patients with TAVR who reached at least 5-year follow-up, as compared to surgical aortic valve replacement (SAVR), performed within the same time-frame at the same institution.
Methods and results
Consecutive patients with at least 5-year available follow-up, who underwent TAVR between November 2008 to December 2015 in a tertiary single center, were included. From a group of 246 patients undergoing TAVR, 126 had available follow-up data (age at implantation: 83.0 [77.8–87.0] years; EuroScore II: 4.54 [2.60–6.29]%; follow-up: 5.94 [5.06–7.67] years). First generation Corevalve® and Sapien® prosthesis were implanted in 56% and 38% patients, respectively.
SVD and BVF were defined according to the new consensus statement from the EAPCI endorsed by the ESC and the EACTS. Mean transaortic pressure gradients decreased from 53.2±1.3 mmHg (pre-TAVR) to 10.4±0.4 mmHg (at discharge or up to one-year after TAVR, p<0.001), and there was a small non-significant increase at the fifth-year and the last available follow-up (11.2±0.6 mmHg; 14.7±1.8 mmHg, respectively). Moderate and severe SVD were reported in 12 and 4 patients, respectively (8-year cumulative incidence function to SVD: 2.67%; 95% CI, 2.12–3.89). Of these 8 had BVF, 7 of them with hospitalization for acute heart failure. A total of 4 patients died and none required reintervention (redo TAVR or SAVR). BVF for non-SVD were observed in 4 patients (2 subclinic thrombosis successfully treated with anticoagulation and 2 paravalvular regurgitation due to endocarditis).
As comparator, from a cohort of 587 patients submitted to biological SAVR, 247 (age 75.0 [70.0–79.0] years; EuroScore II 1.43 [1.06–2.17]%) had available long-term follow-up (6.89 [6.08–8.19] years). Moderate and severe SVD were reported in 42 and 3 patients, respectively (8-year cumulative incidence function to SVD: 3.13%; 95% CI, 2.45–4.21). These events were clinically relevant (BVF) in 19 of them: 8 performed TAVR valve-in-valve procedures and 3 redo SAVR. At the fifth-year of follow-up the incidence of SVD was not statistically different between TAVR (8%) and SAVR (15%), with a p for comparison of 0.137.
Conclusions
In our population of patients with symptomatic severe aortic stenosis treated with first-generation percutaneous bioprostheses, TAVR was associated with a low incidence of BVF and SVD at the long-term follow-up. These outcomes seem indistinct from those occurring in patients submitted to conventional SAVR
Funding Acknowledgement
Type of funding sources: None. KM curve reporting probability of SVD
Collapse
Affiliation(s)
| | - P Lopes
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | | | - L Raposo
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J Brito
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - T Nolasco
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Madeira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | | | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | | |
Collapse
|
27
|
Albuquerque F, Lopes P, Freitas P, Presume J, Gomes D, Abecasis J, Guerreiro S, Santos A, Saraiva C, Mendes M, Ferreira A. Coronary artery calcium score to predict coronary CT angiography interpretability: an old problem revisited. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab111.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Clinical guidelines recommend against the use of coronary computed tomography angiography (CCTA) in patients with heavy calcification due to interpretability concerns, but no specific approach or threshold is provided. Recently, alternative methods have been proposed as more reliable predictors of CCTA interpretability than the classic coronary artery calcium score (CACS). The purpose this study was to compare the performance of different measures of coronary calcification as predictors of CCTA interpretability.
Methods
We conducted a retrospective analysis of consecutive patients undergoing CACS and CCTA between 2018 and 2020. The key exclusion criteria were known coronary artery disease, CACS of zero, and presence of non-assessable coronary lesions for reasons other than calcification (movement/gating artifacts or vessel diameter < 2mm). CCTA studies were considered non-interpretable if the main reader considered one or more coronary lesions non-assessable due to calcification. Three different measures of coronary calcification were compared using ROC curve analysis: 1) total CACS; 2) CACS-to-lesion ratio (total CACS divided by the number of calcified plaques); and 3) calcium score of the most calcified plaque. Decision-tree analysis was performed to identify the algorithm that best predicts CCTA interpretability.
Results
A total of 432 patients (191 women, mean age 64 ± 11 years) were included. Overall, 31 patients (7.2%) had a non-interpretable CCTA due to calcification. Patients with non-interpretable CCTA had higher CACS (median 589 vs. 50 AU, p < 0.001), higher CACS-to-lesion ratio (median 43 vs. 14 AU/lesion, p < 0.001), and higher score of the most calcified plaque (median 445 vs. 43 AU, p < 0.001). Among the 3 methods, CACS showed the highest discriminative power to predict a non-interpretable CCTA (C-statistic 0.93, 95%CI 0.89-0.95, p < 0.001) - Figure.
Decision-tree analysis identified a single-variable algorithm (CACS value ≤ 515 AU) as the best discriminator of CCTA interpretability: 396 of the 409 patients (97%) with CACS ≤ 515 AU had an interpretable CCTA, whereas only 5 of the 23 patients (22%) with CACS > 515 AU had an interpretable test, yielding a total of 96% correct predictions.
Conclusions
The recently proposed and more complex measures of coronary calcification seem unable to outperform total CACS as a predictor of CCTA interpretability. A simple CACS cutoff-value around 500 AU remains the best discriminator for this purpose.
Collapse
Affiliation(s)
| | - P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Presume
- Hospital Santa Cruz, Carnaxide, Portugal
| | - D Gomes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - A Santos
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
28
|
Silva C, Goncalves M, Lopes P, Ventosa A, Calqueiro J, Freitas PN, Guerreiro S, Brito J, Abecasis J, Raposo L, Saraiva C, Goncalves PA, Gabriel HM, Almeida M, Ferreira AM. Patients undergoing invasive coronary angiography after a positive single-photon emission computed tomography or a positive stress cardiac magnetic resonance - What to expect at the cath lab. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeab090.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Randomized controlled trials comparing stress cardiac magnetic resonance (CMR) and single-photon emission computed tomography (SPECT) suggest similar diagnostic accuracy for detecting obstructive coronary artery disease (CAD). However, there are few data on whether or not this remains true in routine clinical practice.
The aim of this study was to assess the clinical and angiographic characteristics of patients undergoing invasive coronary angiography (ICA) after a positive stress CMR or positive SPECT, and to compare their positive predictive value with published results from the CE-MARC trial.
Methods
In this retrospective tertiary-center analysis, we included 429 patients (mean age 67 ± 10 years, 28% women, 42% diabetic) undergoing ICA between January 2016 and December 2020, after a positive stress CMR or positive SPECT. Regarding stress test, an adenosine protocol was performed in all stress CMR and in 76.4% (n = 272) of stress SPECT.
Stress test results, including ischemia location and severity, were classified as reported by their primary readers. Patients with missing data on key variables, and those in whom microvascular disease was considered likely in the original stress test report were excluded. Obstructive CAD was defined as any coronary artery stenosis ≥ 50% in a vessel compatible with the ischemic territory on stress testing.
Results
Out of the total 429 patients, 356 (83%) were referred after a positive SPECT, and 73 (17%) after a positive stress CMR. Patients did not differ regarding age, cardiovascular risk factors, previous revascularization or left ventricular dysfunction, but patients with SPECT were more frequently male (p = 0.046). Overall, 320 patients (75%) had obstructive CAD on ICA. The prevalence of obstructive CAD was similar in patients with positive SPECT vs. positive stress CMR (76.1% vs. 80.8%, respectively, p = 0.385). There were also no significant differences in the prevalence of left main or 3-vessel disease (9.0% vs. 9.6%, p = 0.871, and 19.7% vs. 23.3% p = 0.483, respectively). Revascularization was performed or planned in 59.3% of patients in the SPECT group, and 52.1% of those in the stress CMR group (p = 0.255). The positive predictive values of both techniques were similar to those reported in the CE-MARC trial (Figure), and would increase to 88.1% and 89.4% for SPECT and stress CMR, respectively, if patients reported as having only mild ischemia were excluded.
Conclusion
In this tertiary center analysis, stress CMR and SPECT showed similar positive predictive values, comparable to those reported in the CE-MARC trial.
Collapse
Affiliation(s)
- C Silva
- Hospital de Santa Cruz, Lisbon, Portugal
| | | | - P Lopes
- Hospital de Santa Cruz, Lisbon, Portugal
| | - A Ventosa
- Hospital de Santa Cruz, Lisbon, Portugal
| | | | - PN Freitas
- Hospital de Santa Cruz, Lisbon, Portugal
| | | | - J Brito
- Hospital de Santa Cruz, Lisbon, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Lisbon, Portugal
| | - L Raposo
- Hospital de Santa Cruz, Lisbon, Portugal
| | - C Saraiva
- Hospital de Santa Cruz, Lisbon, Portugal
| | | | - HM Gabriel
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Almeida
- Hospital de Santa Cruz, Lisbon, Portugal
| | | |
Collapse
|
29
|
Sa Mendes G, Ferreira AM, Freitas P, Abecasis J, Campante Teles R, De Araujo Goncalves P, Ribeiras R, Santos AC, Trabulo M, Silva C, Lopes P, Andrade MJ, Saraiva C, Almeida M, Mendes M. Calcium score of the aortic valve as a predictor of aortic stenosis severity. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.227] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
The calcium score of the aortic valve (CaScAoV) is now recommended as a supporting tool to assist in the grading of aortic stenosis (AS) severity when echocardiographic assessment is inconclusive. However, the proposed CaScAoV cut-offs for considering severe AS "unlikely", "likely", or "very likely" have never been validated in Portuguese cohorts.
Aim
The purpose of this study was to assess the performance of the proposed CaScAoV cut-offs in identifying patients with severe aortic stenosis.
Methods
A total of 513 consecutive patients (median age 83 years [IQR 79–87], 38% males) evaluated at a single-centre TAVI-programme between Jan/2016 and Nov/2019 were retrospectively identified. Only patients with an ECG-gated cardiac computed tomography (CT) and a transthoracic echocardiography performed within a 6-month time-frame were included. Main exclusion criteria were left ventricular ejection fraction < 50%, indexed stroke volume < 35 ml/m2, previous valve surgery and
bicuspid aortic disease. CaScAoV was measured according to the Agatston method (Agatston units – AU). As previously reported, the likelihood of aortic stenosis as assessed by CT was categorized as: "very likely" (>3000 AU for men, >1600 AU for women); "likely" (>2000 AU for men, >1200 AU for women) ; or unlikely (<1600 AU for men, <800 AU for women). Diagnostic tests performance measures were calculated for each category. Separate analyses were performed for each gender.
Results
Severe AS (mean gradient ≥ 40 mmHg) was present in 422 patients (overall 82.3%: 83.1% in females and 80.8% in males), with a median transvalvular gradient of 49 mmHg (IQR 42 – 60).
Overall, the discriminative ability of the CaScAoV to distinguish severe from non-severe AS was higher in men when compared with women (c-statistic 0.86 [95%CI 0.80 – 0.93] vs. 0.72 [95%CI 0.64 – 0.80], p for comparison < 0.001). In males, the "very likely" cut-off had a sensitivity of 71% (95%CI 63 – 78%), a specificity of 81% (95%CI 65 – 92%), a positive predictive value (PPV) of 94% (95%CI 89 – 97%) and a negative predictive value (NPV) of 40% (95%CI 33 – 46%) for the diagnosis of severe AS. Conversely, in women the sensitivity was 75% (95%CI 69 – 80%), specificity was 57% (95%CI 43 – 71%), PPV was 90% (95%CI 86 – 92%) and NPV was 32% (95%CI 25 – 39%).
On the other end of the spectrum, the "unlikely" cut-off showed poor performance in dismissing severe AS, particularly in females – NPV of 43% (95%CI 25-63%) in women vs. 83% (95%CI 63-93%) in men.
Conclusion
In our population, the discriminative power of CaScAoV for identifying patients with severe AS was lower than in previously published cohorts, particularly in females. While very high CaScAoV is strongly supportive of severe AS, caution should be employed when interpreting low CaScAoV values in women, since the recommended cut-off value does not allow the safe exclusion of severe aortic stenosis.
Abstract Figure. Waterfall chart of individuals CaScAoV
Collapse
Affiliation(s)
| | | | - P Freitas
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | | | - R Ribeiras
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - AC Santos
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - C Silva
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - P Lopes
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - MJ Andrade
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Almeida
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
30
|
Lopes P, Albuquerque F, Freitas P, Gama F, Horta E, Reis C, Abecasis J, Trabulo M, Ferreira A, Canada M, Ribeiras R, Mendes M, Andrade MJ. Adapting the concepts of proportionate and disproportionate functional mitral regurgitation to clinical practice. Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Despite its theoretical appeal, the concept of Proportionate and Disproportionate FMR has been limited by the lack of a simple way to assess it and by the paucity of data showing its prognostic superiority over currently established ways of grading FMR.
Objectives
This study sought to evaluate the prognostic value of a new and individualized method of assessing Functional Mitral Regurgitation (FMR) Proportionality.
Methods
Patients with at least mild FMR and reduced left ventricular ejection fraction (< 50%) under optimal guideline-directed medical therapy were retrospectively identified at a single-center. To determine FMR proportionality status, we used a novel approach where two simple equations establish an individual cut-off of regurgitant volume/effective regurgitant orifice area, categorizing the study population into non-severe, proportionate and disproportionate FMR (Figure 1). The primary endpoint was all-cause mortality.
Results
A total of 572 patients (median age 70 years; 76% male) were included. Median LVEF was 35% (IQR 28-40) and LVEDV was 169 ml (IQR 132-215). Disproportionate FMR was present in 109 patients (19%) with a median EROA of 26 mm2 (IQR 22-31) and a median RegVol of 40 ml (IQR 34-48), proportionate FMR in 148 patients (26%) with a median EROA of 16mm2 (IQR 12-21) and a median RegVol of 26 ml (IQR 19-32). During a median follow-up of 3.8 years (interquartile range: 1.8 to 6.2 years) there were 254 deaths (44%). The unadjusted mortality incidence per 100 persons-year rose as the degree of FMR disproportionality worsened. On multivariable analysis, disproportionate FMR remained independently associated with all-cause mortality (adjusted hazard ratio: 1.785; 95% confidence interval [CI]: 1.249 to 2.550; P = 0.001). The FMR proportionality concept showed greater discriminative power (C-statistic 0.639; 95% CI: 0.597 to 0.680) than the American (C-statistic 0.588; 95% CI: 0.550 to 0.626; P for comparison = .001) and European guidelines (C-statistic 0.563; 95% CI: 0.534 to 0.591; P for comparison < .001). It was also able to increase the net reclassification index (0.167 [P < 0.001] and 0.084 [P = 0.001], respectively).
Conclusions
A new, simplified and individualized method of assessing FMR Proportionality showed that disproportionate FMR is independently associated with all-cause mortality. This approach seems to outperform the risk stratification of current guidelines.
Abstract Figure 1
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - F Gama
- Hospital Santa Cruz, Carnaxide, Portugal
| | - E Horta
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Reis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Canada
- Hospital Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - MJ Andrade
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
31
|
Lopes P, Albuquerque F, Freitas P, Horta E, Reis C, Abecasis J, Trabulo M, Ferreira A, Canada M, Ribeiras R, Mendes M, Andrade MJ. Regurgitant volume to left ventricular end-diastolic volume ratio: another step to risk stratification in patients with secondary mitral regurgitation? Eur Heart J Cardiovasc Imaging 2021. [DOI: 10.1093/ehjci/jeaa356.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
Quantitative evaluation of secondary mitral valve regurgitation (MR) remains an important yet challenging step in the evaluation of this entity. Its severity can be underestimated when using the proximal isovelocity surface area (PISA) method, which does not take left ventricular (LV) volume into account. Normalizing mitral regurgitant volume (Rvol) for the LV end-diastolic volume (EDV) might overcome this key limitation. This study aimed to investigate the prognostic implication of Rvol/EDV ratio in patients with secondary MR.
Methods
Patients with at least mild secondary MR and reduced left ventricular ejection fraction (<50%) under optimal guidelines-directed medical therapy were retrospectively identified at a single-center. The cohort was divided into terciles according to the RVol/EDV ratio. The primary endpoint was all-cause mortality.
Results
A total of 572 patients (median age 70 years; 76% male) were included. Median LVEF was 35% (IQR 28-40) and LVEDV was 169 ml (IQR 132-215). Median measures of secondary MR were EROA 14 mm2 (IQR 8-22) and RegVol 23 ml (12-34). During a median follow-up of 3.8 years (interquartile range 1.8 to 6.2 years) there were 254 deaths (44%). The unadjusted mortality incidence increases across terciles distribution. Patients at the 2nd and 3rd terciles of the RVol/EDV ratio showed significantly higher mortality when compared to those at the 1st one (baseline reference) (figure 1). After multivariable analysis, terciles of the Rvol/EDV ratio remained independently associated with increased all-cause mortality (considering the 1st tercile as the reference; adjusted HR for the 2nd tercile 1.46 [95% CI 1.05- 2.02] p = 0.023; adjusted HR for 3rd tercile 1.56 [95% CI 1.09 – 2.22], p = 0.015).
Conclusion
In patients with secondary MR, Rvol/EDV ratio is independently associated with all-cause mortality. However, the appropriate cut-off to determine any kind of clinical decision remains to be determined.
Abstract Figure.
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - E Horta
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Reis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Canada
- Hospital Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - MJ Andrade
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
32
|
Sousa J, Matos D, Ferreira A, Abecasis J, Saraiva C, Freitas P, Carmo J, Carvalho S, Rodrigues G, Durazzo A, Costa F, Carmo P, Morgado F, Cavaco D, Adragao P. Epicardial adipose tissue and atrial fibrillation: guilty as charged or guilty by association? Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0468] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Epicardial adipose tissue (EAT) has been linked to the presence and burden of atrial fibrillation (AF). However, it is still unclear whether this relationship is causal or simply a surrogate marker of other risk factors commonly associated with AF.
Purpose
The purpose of this study was to assess the relationship between these factors and EAT, and to compare their performance in predicting AF recurrence after an ablation procedure.
Methods
We assessed 575 consecutive patients (mean age 61±11 years, 62% male) undergoing AF ablation preceded by cardiac CT in a high-volume ablation center. EAT was measured on cardiac CT using a modified simplified method. Patients were divided into 2 groups (above vs. below the median EAT volume). Cox regression was used to assess the relationship between epicardial fat, risk factors, and AF relapse.
Results
Patients with above-median EAT volume were older (p<0.001), more often male (OR 1.7, p=0.002), had higher body mass index, and higher prevalence of smoking, hypertension, diabetes and dyslipidemia (p<0.05). Non-paroxysmal AF was also more common in those with above-median EAT volume. During a median follow-up of 18 months, 232 patients (40.3%) suffered AF recurrence. After adjustment for BMI and other univariate predictors of relapse, three variables emerged independently associated with time to AF recurrence: non-paroxysmal AF (HR 2.1, 95% CI: 1.5–2.7, p<0.001), indexed left atrial (LA) volume (HR 1.006 per mL/m2, 95% CI: 1.002–1.011, p<0.001), and indexed epicardial fat volume (HR 1.87 per mL/m2, 95% CI: 1.66–2.1, p<0.001). None of the classic cardiovascular risk factors were an independent predictor of AF recurrence (all p>0.10).
Conclusion
Classic cardiovascular risk factors are more prevalent in patients with higher amounts of epicardial fat. However, unlike these risk factors, EAT is a powerful predictor of AF recurrence after ablation. These findings suggest that EAT is not merely a surrogate marker, but an important participant in the pathophysiology of AF.
EAT, cvrf and AF burden
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- J Sousa
- Hospital Dr. Nélio Mendonça, Cardiology, Funchal, Portugal
| | - D Matos
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - C Saraiva
- Hospital de Santa Cruz, Radiology, Lisbon, Portugal
| | - P Freitas
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - J Carmo
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - S Carvalho
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - G Rodrigues
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - A Durazzo
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - F.M Costa
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - P Carmo
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - F Morgado
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - D Cavaco
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - P Adragao
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| |
Collapse
|
33
|
Lopes Da Cunha G, Rocha B, Freitas P, Lopes P, Santos A, Guerreiro S, Abecasis J, Aguiar C, Andrade M, Saraiva C, Mendes M, Ferreira A. Unveiling coronary inflammation by perivascular fat angio-CT: a propensity-matched score analysis. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1299] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Inflammation plays a pivotal role in the atherogenic process and recently has been the target of successful clinical trials. A new CT angiography method allows the identification of inflammatory pericoronary fat, which is associated with cardiovascular events. We aimed to determine whether patients with obstructive coronary artery disease (CAD) have a higher pericoronary inflammatory milieu when compared to those without CAD.
Methods
From a prospective CT angiography registry of patients with suspected obstructive CAD, those with a luminal stenosis >70% confirmed by invasive coronary angiography were screened (previous coronary artery bypass grafting was an exclusion criteria). Subsequently, we applied a 1:1 propensity score (PS) without replacement protocol to match obstructive CAD patients with those without CAD (non-CAD), using age, gender, BMI, hypertension, dyslipidemia, diabetes and smoking status as covariates. Similar to previous reports, pericoronary fat characterization by CT angiography was performed by analyzing the fat attenuation index (FAI) at the −30 to −190 HU range. Inflammatory fat was defined by a FAI >−70 HU. The proximal 50mm of the right coronary artery (RCA) was used to perform fat quantification and characterization. The perivascular fat was defined as the adipose tissue within a radial distance from the outer vessel wall equal to the diameter of the vessel.
Results
A matched cohort of 48 patients was identified (mean age 63 years; 77% males) – 24 obstructive CAD and 24 non-CAD patients. Mean FAI was numerically higher in obstructive CAD compared to the non-CAD cohort (−74±7 vs −78±7; p=0.083). Although not statistically significant, those with obstructive CAD had an increased proportion of inflammatory fat (51±10 vs 46±10%; p=0.107). After adjustment for body surface area (BSA), differences in the inflammatory fat proportion became apparent between obstructive CAD and non-CAD patients (28±6 vs 24±5%/m2; p=0.024). Furthermore, we observed a significant correlation between the inflammatory fat proportion (both absolute value and BSA adjusted) and the total number of RCA plaques (r=0.458; p=0.003; and r=0.451; p=0.003, respectively). Finally, there was 1 additional plaque observed in the RCA for each increase in 10% of proportion of inflammatory fat (p=0.018).
Conclusions
Perivascular coronary inflammation, as measured by FAI, seems significantly heightened in patients with obstructive CAD compared to a matched cohort of non-CAD patients. Further studies are needed to ascertain the mechanisms and possible implications of this association.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - C Saraiva
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| | | |
Collapse
|
34
|
Nascimento Matos D, Ferreira A, Cavaco D, Sousa A, Freitas P, Rodrigues G, Carmo J, Abecasis J, Costa F, Santos A, Carmo P, Saraiva C, Morgado F, Mendes M, Adragao P. Epicardial fat volume outperforms classic clinical scores for predicting atrial fibrillation relapse after pulmonary vein isolation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Epicardial adipose tissue has been implicated in the pathophysiology of atrial fibrillation (AF), but its relevance to clinical practice remains uncertain. The aim of this study was to compare the performance of the amount of epicardial fat with previously published clinical scores of AF-relapse risk after pulmonary vein isolation (PVI).
Methods
We assessed 575 patients (354 men, age 61±11 years, 449 paroxysmal AF) with symptomatic AF undergoing cardiac CT prior to a PVI procedure. Epicardial fat was quantified on contrast-enhanced images using a new simplified semi-automated method. The study endpoint was symptomatic and/or documented AF recurrence at 12 months. Epicardial fat was compared against the following scores: MB-LATER, APPLE, DR-FLASH, and ATLAS.
Results
Median follow-up was of 22 months (IQR 12–35), 232 patients relapsed, 130 patients (27%) within the first 12 months. After adjustment for BMI and other univariate predictors of relapse, three variables emerged independently associated with time to AF recurrence: non-paroxysmal AF (HR 2.03, 95% CI: 1.53–2.69, p<0.001), indexed left atrial (LA) volume (HR 1.02 per mL/m2, 95% CI: 1.01–1.02, p<0.001), and indexed pericardial fat volume (HR 1.55 per mL/m2, 95% CI: 1.43–1.67, p<0.001). Based on the ROC curve analysis, the epicardial fat showed greater discriminative power, with a C-statistic of 0.76 (95% CI: 0.71–0.81) against 0.67 (p=0.007 for pairwise comparison of ROC curves), 0.67 (p=0.01), 0.63 (p<0.001) and 0.57 (p<0.001) for the MBLATER, APPLE, DR-FLASH and ATLAS scores, respectively. The C-statistic for indexed LA volume and non-paroxysmal AF AUC were of 0.63 (p<0.001) and 0.61 (p<0.001), respectively.
Conclusion
Pericardial fat volume is a strong independent predictor of AF relapse after PVI, outperforming clinical scores of post-PVI AF. The underlying mechanisms of this association deserve further study.
ROC Curve Analysys
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - A.M Ferreira
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - A Sousa
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - G Rodrigues
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Costa
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - A.C Santos
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| |
Collapse
|
35
|
Gama F, Teles R, Oliveira A, Brizido C, Goncalves P, Brito J, Ferreira A, Abecasis J, Almeida M, Mendes M. Predicting pacemaker implantation after TAVR with procedural CT. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background and aim
The need for permanent pacemaker implantation (PPMI) is a burdensome complication of transcatheter aortic valve replacement (TAVR). Calcium distribution in the aortic-valvular complex (AVC) and, more recently, membranous septum (MS) length seem to be surrogate markers for conduction abnormalities after specific last generation balloon and self-expandable expandable valves. We sough to evaluate whether such pre-procedural association remains across the entire device spectrum.
Methods
Single-centre prospective study of 239 consecutive patients (140 women, median age of 84) with severe symptomatic aortic stenosis patients who underwent ECG-gated contrast-enhanced multi-detector computed tomography (MSCT) before TAVR since Jun/2017. Exclusion criteria were those with previous PPMI, previous bioprothesis, congenital bicuspid valve, and poor imaging quality. The J-score with an 850-Hounsfield unit threshold was used to detect areas of calcium in the region of interest. AVC was characterized by leaflet sector and region, using 3mensio Valves software 7.0 TM. An independent team retrospectively measured MS length blindly by determining the thinnest part of the interventricular septum in the coronal view in the better-defined systolic phase (usually at 40% of the R-R interval, Figure). Device selection (75.8% self-expandable devices, 20.1% balloon expandable, 3.1% other) and positioning were performed according to the operator criteria. Final implant depth was assessed based on the pre-release angiogram or final aortography.
Results
Mortality at 30-days was 1.3% and PPMI occurred in 43 patients (18%). Median MS length was 9.59mm (IQR: 3.11mm). After multivariable logistic regression analysis, MS length emerged as the single significant protective predictor for PPMI (OR: 0.14; 95% 95% CI: 0.05–0.42; p<0.001), independently of the device used (p<0.001). MS length showed strong discriminatory ability for PPMI (c-statistic 0.93; 95% CI 0.88–0.99). Sensitivity/specificity decision plots yielded an MS length of 6.9 mm as the optimal cut-off point for predicting the need for PPMI with a positive and negative predictive value of 91% and 93%, respectively (Figure). There wasn't any calcium accumulation within a specific region of AVC that independently predicted the outcome.
Conclusion
In our experience, a short membranous septum was strongly and independently associated with new permanent pacemaker implantation, regardless of the device type.
Our findings suggest that this simple measure should be routinely made to help device selection and implantation technique.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- F Gama
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - R.C Teles
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - A Oliveira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - C Brizido
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - J Brito
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Almeida
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
36
|
Rocha B, Lopes Da Cunha G, Freitas P, Lopes P, Santos A, Guerreiro S, Tralhao A, Ventosa A, Andrade M, Aguiar C, Abecasis J, Saraiva C, Mendes M, Ferreira A. Lung water quantification by cardiac magnetic resonance imaging: a novel prognostic tool in hf. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiac magnetic resonance (CMR) imaging has recently been proposed to quantify lung water density (LWD, %) non-invasively. Given that pulmonary congestion plays a key role in the pathophysiology of Heart Failure (HF), we designed a study to assess the prognostic significance of a simplified LWD measure in patients with HF and reduced left ventricular ejection fraction (LVEF).
Methods
We conducted a single-center retrospective study of consecutive patients with HF and LVEF <50% who underwent CMR on a 1.5T scanner. Those with severe interstitial lung disease or chronic liver disease were excluded. All measurements were performed in a parasagittal plane at the right midclavicular line on a standard HASTE sequence, which is widely available in all CMR studies. As previously reported, LWD was determined by the lung-to-liver signal ratio multiplied by 0.7. A cohort of 102 healthy controls was used to derive the upper limit of normal (mean ± 2SD) of the LWD (21.2%). The primary endpoint was a composite of all-cause death or HF hospitalization.
Results
A total of 290 HF patients (mean age 64±12 years, 74.8% male, 56.2% of ischemic etiology) with a mean LVEF of 34±10% were included. LWD measurement took on average 35±4 seconds and showed excellent inter-observer agreement (intra-class correlation coefficient >0.90). LWD was increased in 65 (22.4%) patients. Compared to those with normal LWD, the former were more symptomatic (NYHA ≥III: 29.2% vs. 1.8%; p=0.017) and had higher median NT-proBNP [1973 (IQR: 809–3766) vs 802 (IQR: 355–2157pg/mL); p<0.001]. During a median followup of 21 months (IQR: 13–29), 20 (6.9%) patients died and 40 (13.8%) had at least one HF hospitalization. In multivariate analysis, LVEF (HR per 1%: 0.96; CI-95%: 0.93–0.99; p=0.024), creatinine (HR per 1mg/dL: 2.43; CI-95%: 1.25–4.71; p=0.009) and LWD (HR per 1%: 1.06; CI-95%: 1.01–1.12; p=0.013) were independent predictors of the primary endpoint. The findings were mainly driven by an association between LWD and HF hospitalization (HR per 1%: 1.08; CI-95%: 1.03–1.13; p=0.002).
Conclusions
A CMR-derived method for LWD quantification independently predicts an increased risk of death or HF hospitalization in HF patients with LVEF <50%. Our results support LWD measurement as a simple, reproducible and widely available method, further adding to the prognostic role of CMR in this population.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | | | - P Freitas
- Hospital Santa Cruz, Lisbon, Portugal
| | - P Lopes
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | - A Tralhao
- Hospital Santa Cruz, Lisbon, Portugal
| | - A Ventosa
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | | | - C Saraiva
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| | | |
Collapse
|
37
|
Nascimento Matos D, Ferreira A, Sousa A, Rodrigues G, Carmo J, Freitas P, Guerreiro S, Abecasis J, Costa F, Carmo P, Saraiva C, Cavaco D, Morgado F, Mendes M, Adragao P. A machine-learning algorithm to predict atrial fibrillation recurrence after a pulmonary vein isolation procedure. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0586] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Background
Contemporary risk models to predict the recurrence of atrial fibrillation (AF) after pulmonary vein isolation have limited predictive ability. Models with high specificity seem particularly suited for the setting of AF ablation, where they could be used as gatekeepers to withhold intervention in patients with low likelihood of success. Machine learning (ML) has the potential to identify complex nonlinear patterns within datasets, improving the predictive power of models. This study sought to determine whether ML can be used to better identify patients who will relapse within one year of an AF ablation procedure.
Methods
We assessed 484 patients (294 men, mean age 61±12 years, 76% with paroxysmal AF) who underwent radiofrequency pulmonary vein isolation (PVI) for symptomatic drug-refractory AF. Using this dataset, a machine-learning model based on Support Vector Machines (SVM) was developed to predict AF recurrence within one year of the procedure. The following variables were used to feed the model: type of AF (paroxysmal vs. non-paroxysmal), previous ablation procedure, left atrium (LA) volume, and epicardial fat volume (both derived from pre-ablation cardiac CT). The algorithm was trained in a random sample of 70% of the study population (n=339) and tested in the remainder 30% (n=145).
Results
A total of 130 patients (27%) suffered AF recurrence within one year of the procedure. The ML model predicted AF recurrence with 75% accuracy (95% CI 67–82%), yielding a sensitivity and specificity of 25% (95% CI 13–41%) and 94% (95% CI 88–98%), respectively. The corresponding positive and negative predictive values were 62% (95% CI 39–81%) and 77% (95% CI 67–82%), respectively. The relative weight of the variables in the ML model was: epicardial fat 56%, type of AF 23%, previous ablation 14%, and LA volume 7%. A high-risk subgroup representing 10.8% of patients was identified with the ML algorithm. In this subgroup, one-year recurrence was 62%, representing 24% of the total number of recurrences.
Conclusion
A machine-learning model showed high specificity in the identification of patients who relapse during the first year after AF ablation. In the future, these tools may be useful to improve patient selection.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - A.M Ferreira
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - A Sousa
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - G Rodrigues
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - S Guerreiro
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Costa
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| |
Collapse
|
38
|
Nascimento Matos D, Ferreira A, Freitas P, Rodrigues G, Carmo J, Carvalho M, Abecasis J, Carmo P, Saraiva C, Cavaco D, Morgado F, Mendes M, Adragao P. Relationship between epicardial fat and left atrium fibrosis in patients with atrial fibrillation. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0588] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Epicardial adipose tissue (EAT) has recently been shown to be associated with the presence, severity, and recurrence of atrial fibrillation (AF). Although the pathophysiological mechanisms underlying this association remain to be established, several hypotheses have been put forward, including direct adipocyte infiltration, oxidative stress, and the secretion of adipokines causing inflammation and fibrosis of atrial tissue. We hypothesized that the volume of EAT and the amount of left atrium (LA) fibrosis assessed by non-invasive imaging would be significantly correlated in patients with AF, and that both would predict time to relapse after pulmonary vein isolation (PVI).
Methods
Sixty-eight patients with AF being studied for a first PVI procedure underwent both cardiac computerized tomography (CT) and cardiac magnetic resonance (CMR) within less than 48h. EAT was quantified on contrast-enhanced CT images. LA fibrosis was quantified on isotropic 1.5mm 3D delayed enhancement CMR for image intensity ratio values >1.20. Radiofrequency PVI was performed using an irrigated contact force-sensing ablation catheter, guided by electroanatomical mapping. After PVI, patients were followed for AF recurrence, defined as symptomatic or documented AF after a 3-month blanking period. Pearson's correlation coefficient was used for gauging the correlation between EATLM volume and LA fibrosis. The relationship between these two variables and time to AF recurrence was assessed by Cox regression.
Results
Most of the 68 patients (46 men, mean age 61±12 years) had paroxysmal AF (71%, n=48). The mean body mass index (BMI) was 28.0±4.0 kg/m2. Patients had a median EATLM volume of 2.4 cm3/m2 [interquartile range (IQR) 1.6–3.2 cm3/m2], and a median estimated amount of LA fibrosis of 8.9 g (IQR 5–15 g), corresponding to 8% (IQR 5–11%) of the total LA wall mass. The correlation between EATLM and LA fibrosis was statistically significant but weak (Pearson's R = 0.38, P=0.001) – Figure 1. During a median follow-up of 22 months (IQR 12–31), 31 patients (46%) suffered AF recurrence. Four predictors of relapse were identified in univariate Cox regression: EATLM (HR 2.19, 95% CI 1.65–2.91, P<0.001), LA fibrosis (HR 1.05, 95% CI 1.01–1.09, P=0.033), non-paroxysmal AF (HR 3.36, 95% CI 1.64–6.87, P=0.001), and LA volume (HR 1.03, 95% CI 1.01–1.06, P=0.006). Multivariate analysis yielded two independent predictors of time to AF relapse: EATLM (HR 2.05, 95% CI 1.51–2.79, P<0.001), and non-paroxysmal AF (HR 2.36, 95% CI 1.08–5.16, P=0.031).
Conclusion
The weak correlation between EAT and LA suggests that LA fibrosis is not the main mechanism by which EAT and AF are linked. EAT was more strongly associated with AF recurrence than LA fibrosis, which supports the existence of other, more important mediators between EAT and this arrhythmia.
Correlation between EAT and LA
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - A Ferreira
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - G Rodrigues
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M.S Carvalho
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| |
Collapse
|
39
|
Gama F, Rocha B, Freitas P, Ferreira A, Abecasis J, Guerreiro S, Saraiva C, Santos A, Andrade M, Ventosa A, Almeida M, Pintao S, Mendes M. Downstream testing after an halted coronary CT angiography due to high coronary artery calcium score. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and aim
In many centers, coronary artery calcium score (CACS) is performed immediately before coronary CT angiography (CCTA) in order to exclude heavy calcification that could hamper test performance. When high CACS values are found, CCTA is usually aborted and other tests suggested. However, there are no recommendations on which test to pursue, and little data on their diagnostic yield in this setting. The aim of this study was to assess the type and results of downstream testing among patients whose CCTA study was halted due to high CACS.
Methods
Single-centre retrospective study of consecutive patients undergoing CCTA for suspected obstructive coronary artery disease (CAD). A CACS threshold of >400 was generally used to cancel CCTA. Downstream testing and its results were assessed using electronic medical records. A group of consecutive patients with CACS <400 who underwent CCTA was used for comparison.
Results
Of the 795 patients who performed CCTA for suspected CAD, 86 (10.8%), had their test halted due to high CACS (57 men, mean age 71±11 years). In this subgroup, the median pre-test probability for CAD was 27% (interquartile range 25) and the median CACS was 983 (interquartile range 930). Compared to patients who underwent CCTA, those who saw their tests cancelled were older, more frequently male, and had higher prevalence of cardiovascular risk factors and higher pre-test probability for CAD.
Patient's downstream testing is illustrated in Figure. From the 86 patients enrolled, 12 are currently waiting for downstream tests and were excluded from further analysis. Overall, 35 patients ended up performing invasive coronary angiography (ICA, 47.3%) of whom 19 (54.3%) had significant CAD. Among those who underwent non-invasive testing (N=19, 25.7%), 10 (52.6%) had significant ischemia and 4 (21%) underwent additional testing with ICA. In 24 patients (32.4%), no downstream testing was pursued. Finally, 17 (22.3%) patients underwent coronary revascularization, either percutaneous (N=10, 13.5%) or surgical (N=7, 10.8%).
Conclusion
Invasive coronary angiography is the most frequently used downstream test when CCTA is halted due to high CACS values, and shows significant CAD in roughly half of the cases. Considering the high prevalence of significant CAD, direct referral for ICA (with the possibility of invasive functional testing) seems a reasonable approach.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- F Gama
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - P Freitas
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - C Saraiva
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - A.C Santos
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - A Ventosa
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Almeida
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - S Pintao
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
40
|
Lopes P, Albuquerque F, Freitas P, Rocha B, Cunha G, Mendes G, Abecasis J, Santos A, Saraiva C, Mendes M, Ferreira A. Pre-test probability of obstructive coronary artery disease in the new guidelines: too much, too little or just enough? Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Previous 2013 ESC guidelines recommended the use of the Modified Diamond-Forrester method to assess the pre-test probability (PTP) of obstructive coronary artery disease (CAD). The 2019 ESC Chronic Coronary Syndrome guidelines updated this recommendation with a major downgrade in PTP. The aim of this study was to compare the performance of these two methods in patients with stable chest pain undergoing coronary computed tomography angiography (CCTA) for suspected CAD.
Methods
We performed a retrospective analysis on prospectively collected data from a cohort of consecutive patients undergoing CCTA for suspected CAD from October 2016 to 2019. Key exclusion criteria were age <30 years-old, known CAD, suspected acute coronary syndrome or symptoms other than chest pain. Obstructive CAD was defined as any luminal stenosis ≥50% on CCTA. Whenever invasive coronary angiography (ICA) was subsequently performed, patients were reclassified if luminal stenosis was <50%. The two PTP prediction models were assessed for calibration and discrimination.
Results
A total of 320 patients (median age 63 years [IQR 53–70], 59% women) were included. Chest pain characteristics were: 48% atypical angina, 38% non-anginal chest pain, 14% typical angina. The observed prevalence of obstructive CAD was 16.3% (n=52). Patients with obstructive CAD were more often male, were significantly older and had a higher prevalence of typical angina and cardiovascular risk factors (except for family history of CAD). On average, individual PTP was 22.1% lower in the new guidelines. The 2013 prediction model significantly overestimated the likelihood of obstructive CAD (mean PTP 37.3% vs 16.3%; relative overestimation of 130%, p-value for miscalibration 0.005). The updated 2019 method showed good calibration for predicting the likelihood of obstructive CAD (mean PTP 15.2% vs 16.3%; relative underestimation of 6.5%, p-value for miscalibration 0.712). The two approaches showed similar discriminative power, with a C-statistics of 0.730 and 0.735 for the 2013 and 2019 methods, respectively (p-value for comparison 0.933). Stratification by gender produced similar results.
Conclusions
In patients with stable chest pain undergoing CCTA, the updated 2019 prediction model allows for a more precise estimation of pre-test probabilities of obstructive CAD than the previous model. Adoption of this new score may improve disease prediction and change the downstream diagnostic pathway in a significant proportion of cases.
Graph 1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Santos
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| |
Collapse
|
41
|
De Sousa Bispo J, Azevedo P, Freitas P, Marques N, Reis C, Horta E, Trabulo M, Abecasis J, Canada M, Ribeiras R, Andrade M. Mechanical Dispersion as a powerful echocardiographic predictor of outcomes after Myocardial Infarction. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.0126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Abstract
Introduction
Several studies have addressed the importance of transthoracic echocardiography (TTE) in risk prediction of subsequent adverse events after ST elevation myocardial infarction (STEMI). While several traditional echo parameters have a well-established prognostic value, data derived from 2D-Speckle Tracking Echocardiography (2DSTE) needs further investigation.
Objectives
To determine if 2DSTE parameters provide additional information beyond conventional echocardiography to predict long-term adverse outcomes in patients admitted with STEMI
Methods
Retrospective, single-center study, that included all patients without previous cardiovascular events admitted with STEMI (who underwent primary coronary angioplasty) between 2015 and 2017. Patients with poor acoustic windows, severe valvular disease, irregular heart rhythm, and those who died during hospital stay were excluded. We reviewed all pre-discharge TTE to assess conventional parameters of LV systolic and diastolic function and data obtained by 2DSTE: global longitudinal strain (GLS) and peak strain dispersion (PSD), an index that is the standard deviation from time to peak strain of all segments over the entire cardiac cycle. Demographic and clinical data was obtained through electronic hospital records. Minimum follow-up was 2 years. The primary endpoint was a composite of all-cause mortality and cardiovascular re-admission at follow-up. Survival analysis was used to determine independent predictors of the primary endpoint.
Results
377 patients were included, mean age 62±13 years, 72% male. Mean LVEF was 50±10% with 19% of patients having LVEF <40%. Mean indexed left atrium volume (LAVi) was 33±10 ml/m2, mean GLS was −14±4%, and PSD was 60±22 msec. Average follow-up was 36±11 months, with a combined endpoint of mortality and hospitalization of 27% (n=102)
Univariate analysis of echocardiographic variables revealed an association between heart rate, LVEF, indexed LV end-systolic volume, indexed stroke volume, LAVi, GLS and PSD with the endpoint. However, on multivariate analysis only LAVi [HR 1.030 (95% CI 1.009 - 1.051), p-value = 0.005] and PSD [HR 1.011 (95% CI 1.002 - 1.020), p-value = 0.012] remained independent predictors of the primary endpoint.
We determined that a PSD value higher than 52 msec has a sensitivity of 76% and a negative predictive value of 83% for mortality and hospitalization, and that this cut-off point discriminates patients at a higher risk of events in Kaplan-Meier Survival analysis with a Log-Rank p-value=0.001.
Conclusion
PSD derived by longitudinal strain analysis is a promising prognostic predictor after STEMI. PSD outperformed conventional echocardiographic parameters in the risk stratification of STEMI patients at discharge.
Kaplan-Meier Survival Curves
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - P Azevedo
- Faro Hospital, Cardiology, Faro, Portugal
| | - P Freitas
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - N Marques
- Faro Hospital, Cardiology, Faro, Portugal
| | - C Reis
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - E Horta
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - M Trabulo
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - M Canada
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - R Ribeiras
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - M.J Andrade
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| |
Collapse
|
42
|
Abecasis J, Mendes G, Ferreira A, Andrade M, Ribeiras R, Ramos S, Masci P, Gil V. Relative apical sparing in patients with severe aortic stenosis: prevalence and significance. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1987] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Relative apical sparing (RAS) of LV longitudinal strain (LS) is a red flag for diagnostic suspicion of amyloid cardiomyopathy (AC). However, it may present in pts with aortic stenosis (AS), where the prevalence of transthyretin AC is being increasingly reported.
Aim
To describe the prevalence of RAS deformation pattern in patients with AS and its clinical significance.
Methods
We prospectively studied 53 pts (71±8y, 54.7% men) with severe symptomatic AS - mean gradient (AVM): 54.6 mmHg; aortic valve area 0.74cm2, referred for surgical replacement with no previous history of ischemic cardiomyopathy. Beyond ECG and transthoracic echo (TTE), all pts underwent CMR, with tissue characterization before surgery. RAS was defined as average apical LS / average basal LS + average mid LS >1 at 2D LV LS analysis. Aortic valve replacement and septal myocardial biopsy were already performed in 26 pts. AS severity indexes, LV remodelling and tissue characterization were compared in both groups, with and without RAS.
Results
RAS was present in 16 pts (30.8%). There were neither pseudoinfarct pattern or low voltage at ECG, nor infiltration suspicion from CMR study (native T1 value 1047ms [IQR 1028–1084]; ECV 22% [IQR 18–25]). Furthermore, none of the pts had suspicion of amyloid deposition at histopathology. Median CMR LVEF was 64.5% [IQR 51.3–70.8%] and 36 pts (67.9%) had non-ischemic DE, with a median fraction of 6.0% [IQR 4.9–12.7%] of LV mass. Comparing both groups, RAS cohort showed a significantly higher AVM, relative wall thickness, maximum septal thickness, peak systolic dispersion and higher LV indexed mass, DE and lower LVEF at CMR. RAS group has also higher NT pro BNP (Table).
Conclusions
RAS is common in this group of pts despite the absence of clinical and histological signs of myocardial infiltration. RAS occurs with worse indexes of LV remodeling and fibrosis consistent with a more advanced stage of the disease.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - G Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| | | | | | | | - S Ramos
- Hospital Santa Cruz, Lisbon, Portugal
| | - P.G Masci
- King's College London, London, United Kingdom
| | - V Gil
- Hospital dos Lusiadas, Lisbon, Portugal
| |
Collapse
|
43
|
Sa Mendes G, Abecasis J, Ferreira A, Ribeiras R, Saraiva C, Ferreira S, Gil V, Andrade M, Mendes M, Neves J, Campante Teles R, Goncalves P. LV replacement fibrosis in aortic stenosis: prevalence and relation to LV remodelling and function. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1867] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Progressive myocardial fibrosis takes part in left ventricular (LV) remodeling in aortic stenosis (AS) and drives the transition from hypertrophy to heart failure. Replacement fibrosis may be characterized by late gadolinium enhancement (LGE) in cardiac magnetic resonance (CMR).
Aim
To assess the prevalence and association between LGE and indexes of LV function in patients with severe aortic stenosis.
Methods
We prospectively studied 53 consecutive patients (age: 71±8 years [min. 51–max. 84], 54.7% men) with severe symptomatic AS, referred for surgical aortic valve replacement with no previous history of ischemic cardiomyopathy. Aortic valve mean gradient was 54.6 mmHg [IQR 46.6–63.2] and aortic valve area 0.74cm2 [IQR 0.61–0.89]; all patients with high gradient, 4 with low-flow. CMR with tissue characterization (T1 mapping, LGE and extracellular volume by ECV quantification – using 5SD from remote myocardium as signal intensity cut-off), was performed before surgery. AS severity indexes, LV mass, systolic and diastolic LV function indexes including global longitudinal strain (GLS) and torsion were compared in both groups of patients, with and without LGE.
Results
Mid-wall LGE was present in 36 patients (67.9%) with a median fraction of 6.0% [IQR 4.9–12.7%] of LV mass. Native T1 value and ECV were within normal ranges (median values: 1047ms [IQR 1028–1084]; 22% [IQR 18–25], respectively). Median CMR LV ejection fraction and mass were 64.5% [IQR 51.3–70.8%] (11 patients with reduced EF) and 76.5g/m2 [IQR 57.4–94.8g/m2], respectively. Median GLS was −13.9% [IQR −11.4 to −17.0%] and torsion was 24.2° [IQR 19.8–32.5°]. Patients with LGE had significantly higher LV mass (87.1g/m2 vs 63.3 g/m2, p=0.001), worse GLS (−14.4% vs −16.9%, p=0.041) and higher NT-proBNP values (1333.7ng/mL vs 559.9ng/mL, p=0.004) (Figure).
Conclusions
Non-ischemic LGE is common in this group of patients with severe symptomatic high gradient aortic stenosis. As it is more prevalent in patients with more pronounced LVH, lower longitudinal deformation and higher NT-proBNP values, it probably represents a more advanced stage of the disease.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
| | - J Abecasis
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - C Saraiva
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - S Ferreira
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - V Gil
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | - M Mendes
- Hospital de Santa Cruz, Carnaxide, Portugal
| | - J.P Neves
- Hospital de Santa Cruz, Carnaxide, Portugal
| | | | | |
Collapse
|
44
|
Lopes P, Albuquerque F, Freitas P, Gama F, Rocha B, Cunha G, Horta E, Reis C, Ferreira A, Abecasis J, Trabulo M, Canada M, Ribeiras R, Mendes M, Andrade M. Disproportionate functional mitral regurgitation: clinical validation of a new conceptual framework. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.2000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
Disproportionate functional mitral regurgitation (FMR) is a novel concept that tries to identify hemodynamically significant FMR by readjusting the effective regurgitant orifice area (EROA) and regurgitant volume (RegVol) cut-offs according to left ventricular end-diastolic volume (LVEDV) and left ventricular ejection fraction (LVEF). However, this theoretical concept lacks clinical validation. The aim of this study was to assess the clinical significance of disproportionate FMR.
Methods
Patients with at least mild FMR and reduced LVEF (<50%) who underwent transthoracic echocardiography between 2010 and 2014 were retrospectively identified in our laboratory database. Optimal medical therapy (including cardiac resynchronization when indicated) for ≥3 months was a prerequisite for inclusion. Hemodynamically significant FMR was defined as regurgitant fraction >50% and the patient-specific theoretical RegVol cut-off was calculated according to the formula presented in Fig. 1a. The difference between the estimated RegVol by the PISA method and the theoretical RegVol cut-off was considered to represent the haemodynamic burden of MR. The primary endpoint was all-cause death. Patients were censured if mitral intervention or heart transplant was undertaken. Survival analysis was used to assess the effect of disproportionate FMR on mortality in 2 subgroups (LVEF <30% and 30–49%).
Results
A total of 289 patients (median age 69 years [IQR 60–77], 75% male, 53% of ischemic aetiology) were included. More than 90% were on beta-blockers and renin-angiotensin inhibitors, 44% on aldosterone receptor antagonists, and 73% had implanted devices. The median LVEF and LVEDV were 34% (IQR 27–41) and 170mL (IQR 128–220), respectively. Median EROA was 10mm2 (IQR 3–21) and RegVol was 15 mL (IQR 4–30). RegVol distribution across the cohort was: <10mL: 41%; 10–20mL: 18%; 20–30mL: 15% and >30mL: 26%. Disproportionate FMR was present in 83 patients (29%). These patients had significantly higher SPAP values (41mmHg [IQR 33–50] vs. 33mmHg [IQR 29–40]; p<0.001).
During a median follow-up of 44 months (IQR 19–73), 106 patients died. In the LVEF <30% subgroup, age (HR 1.05 per year [1.02–1.08]; p<0.001), LVEF (HR 0.94 per 1% [0.89–0.99]; p=0.042) and TAPSE (HR 0.92 per mm [0.86–0.99]; p=0.030) were independent predictors of mortality. In the LVEF 30–49% subgroup, age (HR 1.05 per year [1.02–1.08]; p=0.003), LVEF (HR 0.94 per 1% [0.89–0.99]; p=0.020) and disproportionate FMR (HR 1.02 per mL [1.01–1.03]; p=0.01) were independently associated with increased mortality.
Conclusions
Disproportionate FMR proved to be an important independent predictor of mortality in patients with LVEF between 30–49%. These findings were not replicated in those with LVEF<30%, where the degree of biventricular dysfunction seems to outweigh all other echocardiographic parameters, leaving FMR as a bystander.
Figure 1
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- P Lopes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | | - P Freitas
- Hospital Santa Cruz, Carnaxide, Portugal
| | - F Gama
- Hospital Santa Cruz, Carnaxide, Portugal
| | - B Rocha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - G Cunha
- Hospital Santa Cruz, Carnaxide, Portugal
| | - E Horta
- Hospital Santa Cruz, Carnaxide, Portugal
| | - C Reis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - A Ferreira
- Hospital Santa Cruz, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Trabulo
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Canada
- Hospital Santa Cruz, Carnaxide, Portugal
| | - R Ribeiras
- Hospital Santa Cruz, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Carnaxide, Portugal
| | | |
Collapse
|
45
|
Rocha B, Lopes Da Cunha GJ, Lopes PM, Saraiva M, Albuquerque C, Cristina S, Proenca G, Abecasis J, Trabulo M, Andrade M, Ramos S, Mendes M. 1098 Atrial thickening: a surprisingly "gouty" heart. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.647] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Case Presentation
A 49 year-old male presented to the emergency department with fever and lower limb myalgia for 5 days. His past history was notable for acute episodes of microcrystalline pyrophosphate oligoarthritis for which he was receiving allopurinol 100mg, colchicine 1mg and prednisolone 5mg. Physical examination was unrevealing. Laboratory workup showed normocytic normochromic anemia (Hb 12.8g/dL), leukocytosis (22 490 /mm3), neutrophilia (86.8%), increased C-reactive protein (CRP
26mg/dL), low procalcitonin (0.82ng/mL) and mildly elevated creatinine-kinase (83 UI/L). The patient was admitted with fever of unknown origin and started on ceftriaxone after blood and urine cultures.
He remained febrile with persistently heightened inflammation. Cultures, infectious and auto-immune tests, bone marrow biopsy, myelogram and abdominopelvic CT scan were negative. Three weeks later, syncope due to complete atrioventricular (AV) block led to temporary pacemaker implantation. Transoesophageal echocardiography (TOE) revealed a left atrial (LA) wall thickening,
evident on MRI as an 8-10mm T2-hyperintensity sign, with right atrial (RA) and ventricular sparing. PET/CT scan showed an 18F FDG uptake exclusively in the LA. As a neoplasia was highly suspected, a transspeptal biopsy was attempted, yet the sample was scarce for analysis. Thus, a biopsy via sternotomy was performed, now sampling both the LA and RA. Indeed, repeated TOE showed de novo RA involvement with a prominent nodular finding (19x24mm) in the lateral wall.
Myocyte inflammation and necrosis accompanied with granulocyte infiltration (mostly neutrophils but also eosinophils) was observed in all samples. There were no findings suggestive of neoplasia. The patient was still on allopurinol, which has been reported to involve the myocardium in a late (type IV) hypersensitivity reaction (the so-called DRESS syndrome), even in the absence of systemic inflammation. Thus, allopurinol was stopped and 1mg/Kg prednisolone was started. The patient
significantly improved and was discharged home with negative CRP the following two weeks. After 1 month, MRI was repeated and no atrial inflammation was found. After 4 months follow-up, he is doing well on 2.5mg of prednisolone and febuxostat 80mg.
Collapse
Affiliation(s)
- B Rocha
- Hospital Santa Cruz, Lisbon, Portugal
| | | | - P M Lopes
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Saraiva
- Hospital of Santarem, Cardiology, Santarem, Portugal
| | | | | | - G Proenca
- Hospital de Cascais, Cascais, Portugal
| | | | - M Trabulo
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Andrade
- Hospital Santa Cruz, Lisbon, Portugal
| | - S Ramos
- Hospital Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital Santa Cruz, Lisbon, Portugal
| |
Collapse
|
46
|
Felix-Oliveira A, Campante Teles R, Ferreira A, Brito J, Goncalves PA, Raposo L, Gabriel HM, Nolasco T, Cunha G, Abecasis J, Saraiva C, Almeida MS, Mendes M. P3382Vascular calcium Index: an imaging tool to predict vascular complications and major bleeding in TF-TAVI. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.0258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Vascular calcification has been associated with worse outcomes in transfemoral TAVI (TF-TAVI). However, there is currently no simple method to assess it and identify different patterns of calcification in an objective and quantitative manner. The purpose of this study was to develop a quantitative score of aortic (Ao) and ileofemural (IF) calcification and to assess its ability to predict life-threatening bleeding (LTB) and major vascular complications during TF-TAVI.
Methods
Case-control single center retrospective study of patients undergoing TF-TAVI between Nov2015 and Aug2018 including 183 consecutive patients (99 women, mean age 83±3 years, mean Euroscore II - ESII - 6.0±4.1). The Vascular Calcium Score was calculated for the entire Ao and IF vessels using a modified Agatston score derived from contrast-enhanced CT images, with calcium threshold locally adjusted for luminal attenuation (mean attenuation + 5x SD). A luminal attenuation threshold >600UH impaired vascular calcium evaluation and patients were excluded. LTB and major vascular complications were adjudicated according to the VARC-2 classification and identified by chart review by and independent team.
Results
Thirty patients (16%) suffered major bleeding and 13 (7%) experienced LTB. Major vascular injury occurred in 11 patients (6%). The median total vascular calcium score (TCS) was 11752 AU (IQR: 6388–19844) and median IF score (IFS) was 2210AU (IQR: 865–4170). TCS indexed for body surface area (TCSi) was predictor of LTB (AUC: 0.78±0.07, p<0.05) and of major vascular complications (AUC: 0.85±0.05, p<0.05). After multivariate analysis, iTCS and glomerular filtration rate (GFR) remained as predictors of LTB with an HR of 1.11 for each increase in 1000UA/m2 of TCSi (95% CI: 1.03–1.18) and 0.94 (95% CI: 0.88–0.985) respectively, independently of the ESII. iTCS and GFR were also independently associated with major vascular complications (p<0.05). Patients with an iTCS above 9750AU/m2 have an odds ratio of 7.7 (95% CI: 2.0 - 29.2) for LTB. This cut-off has a sensitivity of 77% and a specificity of 70% for LTB. Similarly, patients with an iTCS above 9750AU/m2 have an odds ratio of 10.3 (95% CI: 22 - 49.3) for major vascular injury.
Conclusions
A quantitative score for vascular calcification in contrast-enhanced CT images was developed. iTCS was independently associated with life-threatening bleeding and major vascular complications.
Collapse
Affiliation(s)
| | | | - A Ferreira
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - J Brito
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - P A Goncalves
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - L Raposo
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - H M Gabriel
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - T Nolasco
- Hospital Santa Cruz, Cardiac Surgery, Carnaxide, Portugal
| | - G Cunha
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - C Saraiva
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - M S Almeida
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Cardiology, Lisbon, Portugal
| |
Collapse
|
47
|
Sa Mendes G, Abecasis J, Ferreira A, Ribeiras R, Reis C, Nolasco T, Gouveia R, Abecasis M, Mendes M, Ramos S, Neves J. P4657Cardiac myxomas: are we dealing with distinct clinical entities? Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz745.1039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cardiac myxomas are rare, despite being the most common primary cardiac tumours. A significant number of myxomas are discovered accidentally in asymptomatic patients (pts), as there is increased use of non-invasive cardiac imaging. Our aim was to describe the experience of a cardiac surgery centre managing cardiac myxomas during the last 28 years.
Methods
Single-center retrospective study of consecutive pts admitted with the diagnosis of a cardiac myxomas between 1990 and 2018. Registry data concerning clinical presentation, non-invasive imaging assessment and definitive histopathology were collected.
Results
From 154 pts with the diagnosis of cardiac tumours, we identified 106 (68.8%) myxomas (67% females; mean age at diagnosis 61,5±13,1 years). Myxoma diagnosis increased throughout the 3 decades (27 cases until 2000; 26 cases in the second decade; 52 cases from 2010 until present). 30% of the pts were asymptomatic at diagnosis. Obstructive symptoms (heart failure and syncope) and embolic events were the most common complaints among symptomatic pts. Transthoracic echocardiography firstly identified the tumours in 88% of the cases. Cardiac magnetic resonance and computed tomography were performed for further investigation in 7% of the cases. Presumptive pre-operative diagnosis was correct in 83.8% pts.
Surgical excision was successfully achieved in all cases. 89% of the tumours were located in the left atrium with inter-atrial septum implantation (13 in right chambers; 1 valvular tumour). There were 10 multifocal tumours.
At histopathology myxomas were grossly described as mucous jelly appearance (80%), solid (15%) and mixed type lesions (5%). Rare histologic findings were described in 30% of the cases (8 tumours with bone tissue; 1 with forming bone marrow; 4 with endocrine type glandular epithelium; 16 with lympho-plasmocytic infiltrates; 3 with high mitotic grade; 5 with concomitant thrombus).
For a median follow up of 86 [31–214] months there were 15 deaths (2 of them with tumour related deaths). There were 3 recurrences (2 with high mitotic grade histology), mostly occurring 3 years after the first intervention.
Conclusion
In this case series cardiac myxomas are the most common cardiac tumours, with a significant proportion of asymptomatic lesions. Clinical heterogeneity followed polymorphic histology, with recognized differences when compared to classical descriptions of this kind of tumour.
Collapse
Affiliation(s)
| | - J Abecasis
- Hospital de Santa Cruz, Lisbon, Portugal
| | - A Ferreira
- Hospital de Santa Cruz, Lisbon, Portugal
| | - R Ribeiras
- Hospital de Santa Cruz, Lisbon, Portugal
| | - C Reis
- Hospital de Santa Cruz, Lisbon, Portugal
| | - T Nolasco
- Hospital de Santa Cruz, Lisbon, Portugal
| | - R Gouveia
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Abecasis
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Lisbon, Portugal
| | - S Ramos
- Hospital de Santa Cruz, Lisbon, Portugal
| | - J Neves
- Hospital de Santa Cruz, Lisbon, Portugal
| |
Collapse
|
48
|
Nascimento Matos DJ, Ferreira AM, Freitas P, Guerreiro S, Carmo J, Abecasis J, Costa F, Santos AC, Carmo P, Saraiva C, Cavaco D, Morgado F, Mendes M, Adragao P. 1204Pericardial fat volume outperforms classic risk markers in the prediction of relapse after pulmonary vein isolation. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz748.0034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
Pericardial adipose tissue has been implicated in the pathophysiology of atrial fibrillation (AF), but its relevance to clinical practice remains uncertain. The aim of this study was to assess the relative importance of pericardial fat as predictor of recurrence after pulmonary vein isolation (PVI).
Methods
We assessed 453 patients (278 men, age 61±13 years, 348 paroxysmal AF) with symptomatic AF undergoing cardiac CT prior to a PVI procedure. Pericardial fat was quantified on contrast-enhanced images using a new simplified semi-automated method. The study endpoint was symptomatic and/or documented AF recurrence.
Results
Over a median follow-up of 14 months (IQR 7–23), 170 patients (38%) relapsed. Survival analysis showed significant differences in AF-free survival across tertiles of pericardial fat (Figure). Pericardial fat volume was weakly correlated to body mass index [(BMI), Pearson's R=0.34]. After adjustment for BMI and other univariate predictors of relapse, three variables emerged independently associated with time to AF recurrence: non-paroxysmal AF (HR 2.08, 95% CI: 1.51–2.87, p<0.001), indexed left atrial (LA) volume (HR 1.02 per mL/m2, 95% CI: 1.01–1.02, p<0.001), and indexed pericardial fat volume (HR 1.50 per mL/m2, 95% CI: 1.37–1.64, p<0.001). Based on the Wald test, indexed pericardial fat volume was the strongest of these predictors of relapse (X2 values of 20, 13, and 77, respectively). The population attributable risk (PAF) was higher for pericardial fat (PAF=37% for 1st vs 4th quartile) vs LA volume (PAF=11% for 1st quartile vs 4th quartile) and non-paroxysmal AF (PAF=23%). Pericardial fat volume also showed greater discriminate power than indexed LA volume, with a C-statistic of 0.80 (95% CI 0.76–0.85) vs. 0.61 (95% CI 0.55–0.66), p for difference <0.001. The method for quantifying pericardial fat showed high inter-observer reproducibility (Pearson's R=0.90) and was quick to perform (38±3 seconds).
Conclusion
Pericardial fat volume is a strong independent predictor of AF relapse after PVI, outperforming classic risk markers such as LA volume and type of AF. The underlying mechanisms of this association deserve further study. Meanwhile, this simple parameter may help select patients who are more likely to derive sustained benefit from AF ablation.
Collapse
Affiliation(s)
| | - A M Ferreira
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - S Guerreiro
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Costa
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - A C Santos
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Carmo
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - D Cavaco
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Morgado
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Adragao
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| |
Collapse
|
49
|
Sa Mendes G, Teles R, Neves J, Trabulo M, Almeida M, Ribeira R, Abecasis J, Nolasco T, Strong C, Mendes M. P6508Percutaneous versus surgical paravalvular leak: a ten-year tertiary centre experience. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz746.1098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Aims
Paravalvular leak (PVL) presents an incidence ranging from 2–17%. Open heart surgery is considered the standard treatment and there is no consensus regarding the role of percutaneous closure of non-endocarditis PVL.
Methods
Single-centre retrospective study including consecutive patients that had their PVL closed percutaneously or by surgery, after heart team agreement, between 2007 and 2018. The primary goal was to assess mortality and rehospitalizations. The secondary goals were: a) the technical success, defined as reduction in regurgitation [≥1 degree] and b) clinic and laboratorial improvement.
Results
Forty-eight patients were included (mean age of 66±13 years, 56% male), 12 submitted to percutaneous closure and 36 to surgery (74 vs 65 years, p=0,026, respectively), with similar gender distribution. 56% had an aortic PVL, with the remainder having a mitral leak, with no difference between groups. The indications were heart failure in 91% and haemolytic anaemia in 42%. A combination of both indications and NYHA heart failure functional class ≥ III were higher in percutaneous group. The severity of leak was comparable in both groups.
Patients treated percutaneously had a significant higher rate of atrial fibrillation (92% vs 42%), COPD (33% vs 3%), peripheral artery disease (58% vs 22%) and higher EuroScore II (13,1% [7,1 - 19,0 CI 95%] vs 4,1 [2,9 - 6,5 CI 95%], p=0,003).
There was no significant difference between groups with respect to all- cause mortality at 6 months, and to cardiovascular (CV) mortality and CV rehospitalization at 1-year follow-up. The technical success was lower in percutaneous group, but clinic and laboratorial results did not differ (table).
Primary and secondary [(a) tecnical success (b) clinical and laboratorial improvements] endpoints of percutaneous vs surgery paravalvular leak closure Percutaneous PVL closure Surgical PVL Closure p-value Mortality @ 6 M 17% 25% p=1.000 CV Mortality @ 12 M 25% 31% p=1.000 Rehospitalization @ 12 M 18% 21% p=0.694 Technical success (a) 75% 97% p=0.043 NYHA improvement (b) 70% 71% p=0.171 Hb improvement (b) mean Δ: 1.2±1.1 g/dl mean Δ: 1.3±2.5 g/dl p=0.737 LDH reduction (b) mean Δ: −682±828 U/L mean Δ: −473±1215 U/L p=0.577
Conclusions
In this high-risk population, clinical and laboratorial improvement was achieved by both methods. The percutaneous technique seems more appropriate for patients with higher risk, despite a lower technical success in the reduction of the severity of the leak.
Collapse
Affiliation(s)
| | - R Teles
- Hospital de Santa Cruz, Lisbon, Portugal
| | - J Neves
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Trabulo
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Almeida
- Hospital de Santa Cruz, Lisbon, Portugal
| | - R Ribeira
- Hospital de Santa Cruz, Lisbon, Portugal
| | - J Abecasis
- Hospital de Santa Cruz, Lisbon, Portugal
| | - T Nolasco
- Hospital de Santa Cruz, Lisbon, Portugal
| | - C Strong
- Hospital de Santa Cruz, Lisbon, Portugal
| | - M Mendes
- Hospital de Santa Cruz, Lisbon, Portugal
| |
Collapse
|
50
|
Nascimento Matos DJ, Ferreira AM, Gama F, Tralhao A, Abecasis J, Guerreiro S, Freitas P, Cardoso G, Saraiva C, Goncalves P, Marques H, Mendes M. P1773Impact of coronary artery calcium score on cardiovascular risk stratification: a multicenter analysis. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p1773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
| | - A M Ferreira
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - F Gama
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - A Tralhao
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - J Abecasis
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - S Guerreiro
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Freitas
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - G Cardoso
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - C Saraiva
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - P Goncalves
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - H Marques
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| | - M Mendes
- Hospital Santa Cruz, Cardiology, Carnaxide, Portugal
| |
Collapse
|